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Abstract
Childhood respiratory disease remains a major contributor of morbidity and mortality 
globally and both paediatric and adult chronic respiratory illness is increasing in prev-
alence worldwide. This burden of respiratory disease is heaviest in low-middle income 
countries (LMIC), areas that have a high prevalence of known risk factors for respiratory 
disease, such us overcrowding, poverty and environmental air pollution. Much chronic 
respiratory illness has its origin in early life; further low lung function in infancy is as-
sociated with later respiratory illness. However, there is limited data on lung function 
in African infants despite a high prevalence of respiratory disease. Understanding the 
determinants of infant lung function will improve our understanding of prevention and 
management of respiratory disease. 
This thesis aimed to describe lung function in South African infants from six weeks to one 
year and to investigate the impact of prenatal and early environmental exposures on lung 
function in infancy.
Infants enrolled in the Drakenstein Child Health Study, a multidisciplinary birth cohort 
study investigating the aetiology and outcome of early life lower respiratory tract infec-
tions (LRTI), were included. Seven hundred and forty one infants were enrolled from 
June 2012 to February 2015. Infants had lung function measured at six (4-10) weeks 
of age and one year (11-14 months). Measurements, made with the infant breathing via 
a facemask during natural sleep, included tidal breathing, exhaled nitric oxide, sulphur 
hexafluoride multiple breath washout and the forced oscillation technique. Information on 
antenatal exposures was collected using questionnaires and urine cotinine. Household 
benzene was measured antenatally.
The chapters of the thesis are presented as published manuscripts that describe the es-
tablishment of infant lung function for the first time in South Africa and the development 
of normative lung function in the first year of life. The final chapters investigate the impact 
of early life exposures, most notably LRTI, on lung function at six weeks and one year.
The thesis concludes that infant lung function testing is feasible in a community setting in 
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a LMIC like South Africa. Size, gender and ethnicity are important determinants of lung 
function. Lung function of South African infants is not well predicted by European refer-
ence equations, highlighting the importance of using population specific reference data 
when interpreting lung function tests. 
The study identifies several factors including maternal smoking, maternal alcohol and 
household benzene exposure during pregnancy, associated with altered early lung func-
tion. In addition tracking of lung function in the first year of life is described in this cohort 
of African infants living in a high respiratory disease burden setting.  The study identifies 
risk factors for impaired lung function at one year independent of low baseline lung func-
tion: LRTI, household smoke exposure and infant nutrition, factors amenable to public 
health intervention. 
Given the fact that infant lung function tracks into later life and plays a role in chronic 
respiratory disease, preventing respiratory illness in young children, reducing exposure 
to environmental tobacco and maximising nutrition are key priorities in the strengthening 
of child respiratory health. Long-term study of lung function and respiratory disease in 
these infants is a priority in order to develop new strategies to strengthen child health. 
12 
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Childhood respiratory disease remains a major contributor to morbidity and mortality 
globally, with acute lower respiratory illness a leading cause of death in children under 
five years.1 Globally respiratory illness is the commonest reason for children to present 
to healthcare services and for admission to hospital.2-5 The burden of respiratory illness 
is particularly high in low-middle income (LMIC) countries such as South Africa, with 
more than 90% of respiratory infection related deaths occurring in these areas.6 7 African 
infants are particularly vulnerable with 50% of respiratory tract infection related deaths 
occurring in African countries.8 Young children are particularly vulnerable with more fre-
quent and severe disease in the first year of life. Severe lower respiratory tract infections 
(LRTI) are also common and severe in infants with malnutrition and HIV, both important 
paediatric health challenges in Africa.8 9
Early life respiratory infections are associated with later reduced lung function and chron-
ic respiratory illness10 11 and may play a role in the growing prevalence of chronic respi-
ratory disease such as asthma and obstructive pulmonary disease.12 13 Chronic respira-
tory illness is the fourth leading cause of death globally and is responsible for a large 
burden of global morbidity.12 14 This burden is heaviest in LMIC, areas that have a high 
prevalence of known risk factors for respiratory disease, such us overcrowding, poverty 
and environmental air pollution.15-18 Much of the chronic respiratory burden in later life, 
although exacerbated by personal factors such as smoking tobacco, has its origins very 
early in life, even antenatally.19 Hence early life events play an important role in the de-
velopment of respiratory illness in childhood and later life.
Objective measures of lung function can be used to delineate susceptibility to lower 
respiratory tract infections and the impact of these early life events on subsequent lung 
health.  Given the high burden of respiratory disease in early life and it’s association with 
later chronic respiratory disease measuring lung function could help inform appropriate 
new preventive and management strategies.
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Several birth cohort studies from high-income countries have shown that early life lung 
function tracks through to adulthood. Therefore lung function achieved in infancy and 
childhood predicts lung function attained in early adult life and the point from which phys-
iological lung function decline begins20-22; further low lung function in early childhood is a 
known risk factor for acute and chronic respiratory disease in later childhood as shown 
in several studies from high-income countries.23-28 
Both antenatal and early life exposures affect the lung function achieved in childhood. 
Normal lung development is incomplete at birth, and continues during the early childhood 
years. During this time the lungs are vulnerable to damage if exposed to a noxious en-
vironment or exposure. Various factors have been identified as important determinants 
of early life lung function including infant growth29 30, prematurity31, early life respiratory 
tract infections32, maternal disease such as asthma33 or HIV infection,34 35 environmental 
tobacco smoke36 or other household air pollution37 38. This data is predominantly from 
high income settings; there is little data on infant lung function from LMIC and none from 
Africa. Lung function is a complex and coordinated system of central respiratory control 
and lung structure, which includes the airways, lung parenchyma, chest wall, respiratory 
muscles, peripheral and central receptors. It is likely that different exposures will affect 
the maturation and function of this complex system in different ways depending on the 
type, timing and combination of exposures in an individual. 
In view of the large burden of respiratory disease in Africa, understanding the relative im-
pact of antenatal and early life exposures on lung function in African infants is important 
if we are to develop new effective preventive strategies to strengthen respiratory health 
in childhood.
2. Normal lung development
The lungs undergo much growth and maturation during fetal and early postnatal life and 
hence are particularly vulnerable to deprivation or insult during this time.
The structural development of the lung starts in early fetal life with the airway branch-
ing mostly complete by 16 weeks gestation, comprising the conducting zone. After this 
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airways grow in size but not number. The respiratory zone begins to develop with the 
respiratory bronchioles from 16 to 24 weeks when the alveolar development begins. The 
alveolar do not appear until 28 weeks, with mature alveoli present only after 36 weeks 
gestation.39 At birth only a small proportion (probably 15%) of adult number alveoli are 
present with substantial alveoli growth in number during the first 2-3 years of life,40 41
These growth patterns have significant implications for our understanding of respiratory 
disease and subsequent lung health.
Alveoli continue to develop in volume and complexity during early life. The lung volume 
doubles in the first six months of life and triples by a year of age.42 There is a dysynaptic 
growth pattern with the lung parenchyma growing relatively more than the airways during 
this time. Hence infants have a relatively large airway caliber to lung volume ratio com-
pared to adults.43 Lung physiology changes during the first year of life, with decreasing 
compliance and deformability of the chest wall and increase in size and development of 
the airways. Respiratory system resistance reduces with increasing airway size and lung 
volume. Similarly respiratory system compliance increases with increasing lung volume 
and chest wall stiffness.44 The control of breathing, which includes the central medullary 
respiratory center, peripheral receptors, lung receptors and complex feedback mecha-
nisms, develops during fetal life and matures in early post-natal life. Immature breath-
ing control is associated with an irregular breathing pattern with considerable breath-
to-breath variability and periodic breathing, especially noticeable in preterm infants.45 
Response to hypercapnia and hypoxia may also be variable or difficult to sustain in 
very young infants.46 Factors affecting the brainstem, peripheral receptors and feedback 
mechanisms may alter the control of breathing in infants and children. 
3. Measuring infant lung growth and function
To assess the impact of early life exposures or biological factors on normal lung growth 
and subsequent lung health, reliable measures of infant lung function are needed. For 
large epidemiological studies in healthy children these measures ideally need to be easy 
to perform, safe, have good repeatability and be able to accurately detect significant 
changes in lung function outcomes. Measurement of infant lung function has been used 
to assess normal lung growth and development44 47, as an epidemiological tool to identify 
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risk factors for lung disease23 36 and as an objective measure of infant and childhood lung 
disease diagnosis and progression.48-50 However studies have used different methods 
and equipment making comparison between studies difficult. In addition many methods 
of testing are technically difficult and require sedation so have been limited to specialized 
testing centres and to small cohorts. However, more recently techniques such as the 
forced oscillation technique51, multiple breath gas washout technique52, exhaled nitric ox-
ide53 and tidal breathing volume measures54 have been used successfully in unsedated 
infants during quiet sleep. A few recent birth cohort studies in high income countries have 
used unsedated testing in large prospective infant cohorts with adequate success.24 55 56 
However, there are currently no data on infant lung function in African children.
Different antenatal and early life exposures will affect either lung structural development 
as evidenced by reduced lung volumes, ventilation homogeneity, flow ratios and lung 
compliance; or control of breathing with effects on respiratory rate and flow ratios or 
effects on both. As a measure of airway inflammation, exhaled nitric oxide could add 
further information regarding mechanisms for lung function changes. Hence a compre-
hensive range of lung function measures are necessary to most accurately assess the 
effect of early life exposures on lung function development. Used longitudinally measure-
ments can provide information on the timing and long-term impact of exposures on the 
respiratory system. The optimal tests to use depend on feasibility, safety and the ability 
of the test to assess the functional outcome studied. The currently available infant lung 
function tests are discussed below and summarised in TABLE 1.
3.1 Measurement of lung volumes 
Lung volumes can be measured in infants using the whole body plethysmograph, in-
ert gas multiple breath washout (MBW) or tidal volumes by simple measures of tidal 
breathing analysis. Plethysmography and MBW testing measure the functional residual 
capacity (FRC), a static lung volume that is a representative measure of lung growth and 
also important in the interpretation of volume specific lung function outcomes such as 
airway resistance and forced expiratory flows. The FRC is a balance between the chest 
wall and lung recoil , with changes in either affecting the FRC. Factors that decrease al-
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veolar growth, cause lung atelectasis, decrease lung compliance or increase chest wall 
compliance will all lower the FRC. Airway obstruction with air trapping will raise the FRC. 
In infancy, due to the very compliant chest wall, infants control the FRC dynamically to 
prevent airway collapse. Hence in infancy the FRC variability is also influenced by con-
trol of breathing.
3.1.1 Plethysmography
Infant plethysmography requires specialised equipment and highly skilled staff to accu-
rately measure the FRC. Commercial equipment is available and recommendations for 
standardised equipment and technique have been published.57 58 Adequate reference 
data are lacking however with most published data generated from small cohorts, using 
variable equipment and methodologies. There is no data from African infants. 
Infant plethysmography has been used in prospective cohort studies assessing premor-
bid lung function and risk of respiratory disease in early life.59 60 In a London infant cohort 
study Dezateux et al tested 118 sedated infants soon after birth, measuring the FRC us-
ing whole body plethysmography (FRCpleth) with 91.5% success rate and measured 100 
of them again successfully at one year of age.60  They were able to use plethysmograph-
ic measures to demonstrate tracking of FRCpleth over the first year of life and assess the 
association of baseline FRCpleth on increased risk of wheeze episodes in the first year.
60 
This test affords the opportunity of monitoring changes in lung growth during a critical 
period of lung development. One of the advantages of this measurement technique over 
other measures of FRC such as inert gas MBW (FRCMBW) is that it more reliably reflects 
total thoracic volume. FRCMBW measures the thoracic volume in communication with the 
airway opening and hence may under-report the lung volumes in the presence of gas 
trapping, that is FRCpleth may be higher than FRCMBW in the presence of obstructive lung 
disease.61 Another advantage of plethysmography is that in addition to measuring lung 
volumes airway resistance and specific airway resistance can be measured simulta-
neously, see below.  However, this technique requires the infant to be sedated and is 
resource intense, hence still remains a test for specialised laboratories.
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3.1.2. Inert gas multiple breath washout
An alternative method for measuring the FRC in infants is the inert gas MBW technique. 
This has gained favour in infant lung function testing given that it is non-invasive, can 
be collected during tidal breathing without special respiratory manoeuvres62 and can 
be collected in unsedated infants.56 63 This makes it more feasible for testing large co-
horts of healthy infants. Commercial equipment is available and international consensus 
recommendations for collection and interpretation of this technique have been recently 
published.62 
A prospective Swiss birth cohort measured sulphur hexafluoride (SF6) MBW in 352 
healthy unsedated infants (age mean±sd 5.1±0.8 weeks) with a success rate 57% and 
an intra-individual coefficient of variation for FRC of 6.3% (IQR 4.4 to 8.2).56 In 64 unse-
dated healthy term infants at birth tested with the same methods and equipment, Hul-
skamp et al had a success rate of 90%.63 SF6 MBW testing has been used successfully 
in unsedated infants to assess the impact of infant demographics and early life expo-
sures on FRC.56 63 64 An alternative, the nitrogen MBW techinique requires the breathing 
of 100% oxygen which has been shown to alter the infant breathing pattern and is not 
recommended for use in infants.65 66 The MBW testing technique has been able to detect 
the impact of prematurity63 and cystic fibrosis64 on early life FRCMBW, adding to current 
understanding of the effect of early life events or disease have on normal lung growth.
In summary the inert gas MBW testing can be successfully undertaken in unsedated 
infants during quiet tidal breathing. These measures are sensitive enough to detect the 
impact of early life exposures. An additional advantage of this test is the ability to simul-
taneously measure indices of ventilation homogeneity such as the lung clearance index 
(LCI), see below. 
3.1.3 Tidal breathing volumes
Tidal volume can be relatively easily measured during tidal breathing. The advantage of 
tidal breathing flow volume loop (TBFVL) measurement is that it requires no respiratory 
manoeuver, can be achieved in unsedated infants during quiet tidal breathing and has 
been used in many infant cohort studies facilitating comparison between groups.23 29 55 56 67 68 
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However lung volumes and flow measured during tidal breathing, though relatively sim-
ple to collect, are less simple to interpret. Tidal volume is a function of multiple parts of 
the complex respiratory control mechanism,69 70 and tidal breathing parameters probably 
reflect both respiratory mechanics and control of breathing. For this reason changes 
in tidal volume are a less specific measure of lung growth than the FRC. Standardised 
recommendations on tidal breathing measures have been published and commercial 
equipment is available.71 Although reference data for infant tidal breathing have been 
published,56 70 72-74 these were collected from mostly small samples and in variable wake 
states (natural sleep,56 73 sedated70 or awake74) from Caucasian infants, and hence any-
one using these measures should ideally produce reference data from their own popula-
tion. There is no data from African infants.
Many cohort studies have used TBFVL to measure the impact of early life demographics 
and exposures on tidal volume and flows and association of these measures with sub-
sequent wheeze.23 73-75 These studies have shown value in documenting association of 
low lung function with subsequent wheezy respiratory disease23 73 75 and the reduced lung 
function in infants whose mother smoke during pregnancy.74 76 77 Tidal breathing mea-
sures have also been used in longitudinal studies to asses lung function over time.67 78 
There is much discussion about what are the most valuable measures and how useful 
these measures are in the detection of lung function impairment.70 The most commonly 
reported measures are respiratory rate, tidal volume, time to peak tidal expiratory flow 
(tPTEF), total expiratory time (tE) and the ratio tPTEF/tE. The latter outcomes are discussed 
further below. Tidal volume increases in a non-linear manner with somatic growth in the 
first year of life and then continues to increase with somatic growth through childhood.79 
The advantages of this test include the ease of collection and the ability to use these 
measures longitudinally. In addition they represent the result of the complex control of 
breathing and, although not specific, the various outcomes can provide information about 
respiratory control e.g. respiratory rate, minute ventilation and inspiratory flow ratios; 
lung growth e.g. tidal volume and airflow obstruction e.g. expiratory flow ratios. However, 
when interpreting these outcomes, the non-specific nature of these measures needs to 
be taken into account. 
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3.2 Measurement of air flow
Air flow can be measured in infants either as forced expiratory manoeuvers, infant spi-
rometry, or as tidal breathing flow volume loops. Infant spirometry measures maximal 
flow at forced vital capacity, forced expiratory volumes in unit time and expiratory flow at 
percentage forced vital capacity (FVC). In this way they are similar to measures of forced 
expiration collected with standard paediatric and adult spirometry, a commonly used lung 
function tool in older children and adults. Small lung volumes and small or obstructed air-
ways would result in reduced expiratory flows. Inspiratory and expiratory flows measured 
during tidal breathing have also been used to assess lung function and airway obstruc-
tion in infants. Tidal breathing measures are however less sensitive measures of air flow 
limitation compared to forced manoeuvres as the tidal measures are affected more by 
control of breathing than the forced manoeuvres. 
3.2.1 Infant spirometry
Measurement of forced expiratory flows from total lung capacity to residual volume is 
the most commonly used clinical assessment of lung function in co-operative children 
and adults. These manoeuvres are possible in spontaneously breathing sedated infants 
using specialised techniques. This can be done using the rapid thoracic compression 
(RTC) manoeuvres either from tidal volume80 or over a larger volume by raising lung 
volume above tidal inspiration before the thoracic compression, raised volume RTC 
(RVRTC). 81 The RTC squeezes out air at the end of tidal or raised volume inspiration by 
a compression of an inflatable jacket which applies an external pressure to the chest wall 
and abdomen. The technique requires sedation of infants as well as a highly skilled tech-
nician with special knowledge of respiratory physiology in order to obtain accurate and 
safe infant measurements. Standardised methods have been published, but adequate 
reference data is lacking.80 81
These forced manoeuvres rely on the physiological concept of flow limitation, the point 
at which expiratory flow becomes effort independent. The partial flow volume curves 
obtained from tidal RTC are most commonly quantified by the maximal expiratory flow at 
FRC (VmaxFRC). This measure represents the function of smaller, peripheral airways.
82 
However the disadvantage of this test is the lack of a reliable baseline volume for the 
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measurement of VmaxFRC. This limitation led to the development of the RVRTC tech-
nique which uses a predetermined lung volume via a given inflation pressure, allowing 
the calculation of volume-time parameters. The most commonly reported measures are 
FVC, and forced expiratory flows (FEF) at 25%, 75% and 85% of FVC and the  average 
flow between 25-75 % of FVC (FEF25-75). The forced expiratory flow measured in this 
way has comparable within-subject variability to that obtained by standard spirometry in 
preschool children.83
Many birth cohort studies have used the RTC 23 26 30 32 75 84-86 and more recently the RVRTC87 88  
technique to measure sedated infant lung function and to assess the impact of early life 
factors on lung development and respiratory illness in the first few years of life. 
The main advantage of this test is the ability to measure forced expiratory flows and 
volumes at FVC, measurements that are commonly used to assess pulmonary function 
in older children and adults. In addition this technique is a more sensitive measures of 
airway obstruction than tidal breathing expiratory flows.68 However the disadvantage of 
this technique is the requirement for complex equipment and need for sedation. Differ-
ences across laboratories in technique of raising lung volume have led to limitations in 
comparing data across sites. The need for sedation reduces its applicability to epidemio-
logical studies of healthy infants. Although more sensitive than tidal breathing measures, 
neither technique is able to separate the contribution of airway size and mechanics to 
lung function outcomes and like other measures of lung function are unable to definitively 
identify the site of lung function changes.
3.2.2 Tidal breathing measures of flow
As discussed above, measures of tidal inspiratory and expiratory flows have been com-
monly used as measures of infant lung function in epidemiological and clinical studies. 
Reduced expiratory flow ratios, most commonly the peak tidal expiratory flow over the 
total expiratory time (tPTEF/tE), have been associated with infant respiratory disease and 
early childhood wheeze.23 73 85 The  tPTEF/tE is decreased in children with wheezing dis-
orders,72 acute bronchiolitis89 and after bronchoprovocation testing.90 Factors affecting 
the tPTEF/tE include the elastic recoil pressures of the respiratory system, the resistance 
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to flow in the airways and control of breathing, particularly in early life where expiratory 
breaking and stretch receptor reflexes interact to control the end-expiratory lung volume 
and optimise ventilation.91 Hence this measure, though related to airway obstruction is 
also affected by other aspects of breathing control. 
However its frequent use in prior epidemiological studies and the fact that it can be com-
pleted safely in unsedated infants, makes measurement of tidal breathing outcomes a 
useful tool for longitudinal assessment of a healthy birth cohort in a community setting. 
3.3 Measurement of lung mechanics
Respiratory mechanics describe the resistive, elastic and inertive forces that need to 
be overcome for ventilation to happen efficiently. The mechanics are described by the 
relationship between the changes in pressure, flow and volume during breathing and 
include the mechanical properties of the airways, lung tissue and chest wall. Mechanical 
properties are usually described by compliance (C), resistance (R) and its reciprocal 
conductance (G). If these measures are related to the lung volume at which they were 
measured, it is termed specific resistance (sR) or compliance (sC). Respiratory mechan-
ics may be measured in various ways. These include passive measurements i.e. when 
the respiratory muscles are at rest such as during apnoea or active measurements when 
the muscles are actively contracting. An example of passive measurements is the occlu-
sion technique and active measurements, the interrupter, plethysmographic and forced 
oscillation techniques. Different tests describe different aspects of respiratory mechan-
ics. For example, by measuring changes in alveolar pressure airway resistance (Raw) 
can be measured such as is done by plethysmography. Respiratory system resistance 
(Rrs) can be calculated as change in pressure at the airway opening e.g. single occlusion 
technique. However, no commonly used techniques are able to distinguish between the 
relative contributions from lung tissue, intra- and extra thoracic airways.
3.3.1 Single breath occlusion technique (SOT)
The SOT measures the alveolar pressure during a brief occlusion of the airway and ap-
noea induced by the Hering-Breuer reflex, so that the respiratory muscles are relaxed. 
The pressure measured reflects the elastic recoil pressure of the respiratory system at 
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any given volume. This technique measures respiratory system compliance (Crs), resis-
tance (Rrs) and time constant (Crs x Rrs). Standard recommendations for applying SOT 
have been published92 and commercial devices are available, although adequate refer-
ence data is lacking. SOT has been used in unsedated infant cohorts.24 55 The Wheezing 
Illness Study Leidsche Rijn (WHISTLER) study, a birth cohort study investigating the 
determinants of early life wheezing, collected quality measures of respiratory C and R in 
a large group of infants tested at average 4.6±1.3 weeks.93 They had a 73% success rate 
in unsedated SOT testing and were able to show associations of baseline lung function 
with subsequent disease risk.24 
The SOT has the advantage of being relatively non-invasive and possible in unsedated 
infants. It contributes information regarding the elastic and resistive properties of the 
respiratory system. It has been used successfully as an epidemiological tool in healthy 
unsedated infant cohorts. Disadvantages are that the technique relies on the assumption 
of the lung as a single compartment model. This is particularly problematic in disease 
states. It also assumes near instantaneous equilibration of pressure at the mouth during 
the brief occlusion. This may not be the case in severe airway obstruction or in very 
young infants who have exaggerated respiratory reflexes, and hence theoretically may 
not respond with the Hering-Breuer reflex. Similarly prolonged expiratory breaking may 
delay this equilibration and lead to inaccurate measures.94 In addition, although it has 
been used as an epidemiological tool, it may not be as sensitive a discriminator of clinical 
disease as plethysmographic Raw.
95
3.3.2 Interrupter technique
Interrupter resistance (Rint) is collected by measuring the flow and pressure at the airway 
opening. It uses a shutter-device to briefly interrupt airflow. The change in pressure at 
the airway opening during the occlusion is used to estimate the driving pressure across 
the airway at the time of the interruption.96 The Rint is hence a representation of the air-
way resistance (Raw), but does contain elements of chest wall and lung tissue resistance, 
hence Rint is usually higher than plethysmographically measured Raw.
97  The technique 
also relies on the assumptions of instantaneous shutter closure and equilibration of pres-
sure at the airway opening with alveolar pressure. Recommended equipment and testing 
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standards have been published, but internationally applicable reference data is lacking.98 
Although used in preschool children this technique has been less used in infants. It has 
however been successfully used in unsedated infants in a prospective birth cohort study 
measuring lung function at six weeks of age in healthy infants.56 This study had 72% 
success rate in obtaining successful measures in unsedated infants, but with a high vari-
ability, median intrasubject coefficient of variation of 19% (IQR 14.7 – 25.3).
The primary advantage of the interrupter technique is that it is non-invasive, can be com-
pleted during unsedated sleep during tidal breathing; the equipment is portable and com-
mercial machines are available. However the dependence of this test on instantaneous 
equilibration of pressures during the shutter closure makes it potentially inaccurate in 
the presence of airway disease and could lead to a systematic bias in results between 
disease and healthy participants. In addition, like with many infant techniques for mea-
suring respiratory system resistance, the inclusion of the nasal passages and cheeks 
can further reduce accuracy. Paying special attention to cheek support and equipment 
standards is important.99
3.3.3. Forced oscillation technique (FOT)
The FOT as a measurement of respiratory mechanics has recently gained in popularity 
particularly because it can be done quickly during tidal breathing and requires no respi-
ratory manoeuvre and minimal patient co-operation. The underlying principle of the FOT 
is the application of an external driving signal to the respiratory system and the measure-
ment of the respiratory system response to that applied force. From this response the 
respiratory impedance (Zrs) is derived, this is the frequency-dependent relationship be-
tween pressure and flow. Impedance describes the resistive (pressure changes in phase 
with flow) component and the reactive component (pressure changes out of phase with 
changes in flow) of the respiratory system. The reactive component describes the elastic 
properties of the tissues and the inertial properties of air flow in the airways. The signal or 
sound wave generated from a loudspeaker is applied as input impedance at the airway 
opening. Although much infant work using a low frequency FOT (LFOT) suggested that 
the frequency dependence allowed one to partition the respiratory system response from 
tissues and airways this has not been consistently shown. 
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Most commercially available equipment uses a medium frequency signal that measures 
the resistance and reactance of the respiratory system as a whole and cannot be used to 
partition the response between tissues and airways. There is currently no commercially 
available equipment suitable for use in infants. Recommendations for data collection, 
quality control and reporting have been published.100
FOT has already been well validated for use in children and adults and is able to discrim-
inate between health and disease in a number of paediatric diseases including asthma 
101 102, bronchopulmonary dysplasia103 and cystic fibrosis. 51 However FOT in infants has 
not been routinely used. More recently a FOT technique modified for use in unsedated 
sleeping infants has been developed.104 This modification uses a medium range of fre-
quencies (8 to 48 Hz) and provides estimates of respiratory system resistance, compli-
ance and resonant frequency; as such this test reflects the growth and maturation of both 
the airways and lung parenchyma. This technique has not been used in infant epidemio-
logical studies, but if sensitive enough to detect the impact of early life exposures on lung 
function and growth would be an ideal tool to longitudinally measure lung mechanics 
during early life through to adulthood. 
FOT has the advantage of being a non-invasive tool and is particularly useful in the 
measurement of lung function in infants and children who are unable to co-operate with 
standard lung function measures, which require controlled respiratory manoeuvers. It is 
collected during tidal breathing, removing the need for breathing interruption or sedation. 
Moreover the frequency dependence and the possibility of breath-by-breath analysis of 
data, provide the potential to more sensitively gather information regarding respiratory 
system structure and effect of respiratory disease.
The main disadvantage of this technique in infants is the inclusion of the upper airway in 
the measurement. The measured impedance therefore contains contributions from the 
upper airways and nasal passages which have high resistance105 and the upper airways 
act as a shunt which absorbs a certain amount of the applied signal. This needs to be 
taken into account when collecting and interpreting results. 106
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3.3.4 Plethysmography airway resistance
The resistance of the airways (Raw) can be measured by whole body plethysmography 
which measures the changes in box pressure as representative of alveolar pressure and 
relates this to changes in flow at the mouth. The resistance measured and its reciprocal 
conductance represents that of the airway resistance and conductance. When related 
to the lung volume measured (sRaw and sGaw) it is a measure of the effective airway size 
corrected for lung size and thereby somatic growth.107 These measures are taken during 
quiet tidal breathing and hence non-invasive, although do require sedation. Recommen-
dations for testing standards and commercial equipment are available, but appropriate 
reference data is lacking.57 This technique has been used in birth cohort studies from 
high income countries in sedated infants to describe airway resistance and the impact of 
early life exposures on respiratory mechanics over time.59 60
The main advantage of the plethysmographic measurements are the rapid non-invasive 
measurement of airway resistance that can be related to simultaneously collected FRC. 
However, the equipment is expensive and bulky and hence not a portable field tool. It 
is also not suitable for very small or sick infants, such as preterm infants or infants with 
respiratory infections. Testing requires very experienced and skilled staff e.g. careful 
attention has to be paid to pressure changes due to changes in temperature and humid-
ity during the respired air throughout the testing, adding to the technical difficulties of 
achieving accurate results. In addition testing requires sedation which reduces its feasi-
bility in large cohort studies of healthy infants.
3.4 Measurement of ventilation homogeneity
Another important functional property of the lung is intrapulmonary gas distribution and 
mixing, which is relatively evenly distributed or homogenous in the healthy lung. This can 
be measured in infancy using the MBW technique.108 Using indices measured from the 
washout curve, ventilation inhomogeneities can be calculated. The most commonly used 
index is the lung clearance index (LCI), but other more sophisticated indices include 
the moment ratios (M1/M0 and M2/MO),109 the alveolar gas dilution number52 109 and 
the mixing ratio (the ratio of actual and ideal breaths required to reduce the starting gas 
concentration to the predefined end point)110. The indices of ventilation homogeneity are 
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independent of age and hence potentially useful longitudinal markers of lung function. 
3.4.1 Lung clearance index
The MBW technique can be used to measure the efficiency and distribution of ventilation.62 
The most commonly reported measure of ventilation homogeneity is the lung clearance 
index (LCI) which has been successfully used in infants.52 63 111 112 An increased LCI is evi-
dence of impaired gas mixing or ventilation distribution and is a sensitive measure of pe-
ripheral airway obstruction and early lung damage in infants and young children.111 113 114 
The lung clearance index is defined as the cumulative expired volume needed to low-
er the end-tidal marker gas concentration to 1/40th the starting by the FRC, that is the 
number of FRC turnovers needed to clear the marker gas from the lungs. Consensus 
recommendations have been recently published62 and commercial equipment for infant 
testing is available, however no internationally applicable reference data are currently 
available.  Unsedated MBW testing in infants has been successfully undertaken in cohort 
studies.56 63 
An advantage of the LCI is that this is measured during quiet tidal breathing and so can 
be completed in very young children. In addition this measure, as a function of the FRC, 
changes little through life and can potentially be used to track lung function from infancy 
through childhood to adulthood. Another advantage is the potential for this test to detect 
early peripheral lung disease and has been shown to be a more sensitive measure of 
lung disease than measures of expiratory flow in children with cystic fibrosis.113 A disad-
vantage of the test is that it takes time and needs to be collected during quiet breathing 
free of sighs or respiratory pauses, hence is less feasible in unsedated infants than mea-
sures of lung mechanics for example. The MBW test is resource heavy; equipment is ex-
pensive and requires skilled operators to ensure accurate collection and analysis of data. 
3.5 Measurement of airway inflammation
Assessing airway inflammation is important in investigating the underlying pathophysiol-
ogy of many respiratory diseases. In addition measuring markers of airway imflammation 
may assist in monitoring respiratory disease and treatment in children with inflammato-
ry lung disease such as asthma. Methods used to assess airway inflammation include 
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measurement of blood, urine, sputum, exhaled breath condensate and exhaled breath 
nitric oxide. Products of inflammatory cells such as eosinophils can be measured in the 
blood (e.g. eosinophilic cationic protein) and urine (e.g. eosinophil protein X) and have 
been associated with symptom control in asthmatic children.115 116 Sputum analysis for in-
flammatory cells, in particular eosinophils, has also been associated with asthma symp-
tom control in adults and children,117 118 and has identified non-eosinophilic inflammation 
as important in some patient sub-groups.119 In infants this requires sputum induction. 
Exhaled breath condensate (EBC) is a non-invasive method of collecting a respiratory 
specimen. EBC contains a large number of mediators associated with respiratory dis-
ease and hence a potentially useful tool to measure the inflammatory mileu of the respi-
ratory tract.120  One of the most studied and measured exhaled inflammatory markers is 
nitric oxide which can be collected during tidal breathing in infants.53
3.5.1 Exhaled nitric oxide
Analysis of exhaled breath may play a role in understanding disease mechanisms, aid in 
diagnosis and in clinical management of chronic respiratory disease. Exhaled nitric oxide 
(eNO) is a measure of eosinophilic airway inflammation. In infants it has been shown to 
be raised in infants of atopic mothers 121, those with a history of recurrent wheeze122 and 
those exposed to air pollution.38 Exhaled NO levels may also be affected by age, gender, 
ambient NO, diet, smoking habits and disease states such as cystic fibrosis and primary 
ciliary dyskinesia.123 
Tidal breathing measures of eNO have been successfully measured in unsedated in-
fants.53 122 The measurement is a quick and non-invasive test that can be collected during 
quiet tidal breathing in unsedated infants. It adds novel information to understanding 
lung health that is not provided by other measures of lung growth and function; hence it 
may add information regarding the mechanism behind loss of lung function, particularly 
in wheezy infants. A disadvantage with tidal breathing measures in infants using a face-
mask is that it includes eNO from the upper as well as lower airways. As nasal eNO is 
usually higher than that from the lower airways this can raise the measurement.124
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4. Antenatal and early life determinants of infant lung function
In response to the growing understanding of the early origins of disease, there have 
been a number of studies investigating the antenatal and early life determinants of infant 
lung function. Most of this work has taken place in high-income settings, with minimal 
data from LMIC and none from African infant populations. 
Adverse events during pregnancy may have direct effects on the growing fetus e.g. ma-
ternal smoking is associated with reduced infant birth-weight125; or may prime the infant’s 
body to maladaptive responses to events in later life e.g. in utero maternal smoking and 
increased postnatal responses to allergen exposure.126 The latter falls within the devel-
opmental origins of health and disease (DOHAD) hypothesis, first described by Barker in 
his epidemiological studies which showed that areas with a high infant mortality also had 
a high incidence of adult death from diseases such as respiratory disease.127 128 The DO-
HAD hypothesis suggests that an in-utero event reprograms an individual to survive the 
in-utero environment with consequent increased risk for systemic disease in later life.129 
Trans-generational epigenetic effects have also been described in respiratory disease. 
For example in utero smoke exposure is associated with a higher risk of asthma de-
veloping two generations later. A grandmother who smokes increases the chance that 
her grandchild will develop asthma, even if the child’s mother does not smoke.130 Other 
important exposures have a similar effect e.g. exposure to air pollutants or alcohol. This 
adds another complex layer to understanding the determinants of respiratory disease.
A number of birth cohort studies have investigated the effect of in utero exposures on 
early life lung function, identifying factors associated with lung function achieved soon 
after birth and at one year. The various infant cohort studies are summarized in TABLE 
2, including details of sample size, participants and lung function testing. Because infant 
lung function was until recently restricted to highly specialized units and equipment and 
testing methods were not standardized, many early studies had small sample sizes and 
used variable techniques and equipment making comparisons between studies difficult. 
However, many factors have emerged as important in determining early lung function 
achieved.
33
4.1 Infant growth 
Children and adults who were small at birth have lower lung function 131 132 and increased 
risk of respiratory disease and death in later life.10 133 Infant lung function measures are 
dependent on body size, therefore it is expected that larger infants would have larger lung 
volumes with improved flows and lung mechanics.29 Gestational age adjusted weight at 
birth, a reflection of fetal growth, is however independently associated with lung function 
in early life.29 30 33 134 Dezateux et al, in a population based cohort of full-term infants with 
six week lung function measures, found infants who were small for gestational age had 
lower lung volumes, flows and respiratory system compliance at 6 weeks compared to 
infants born appropriate for gestational age, an effect independent of weight and length 
at test.33 This effect persisted during the first year of life.29 This suggests that factors 
causing impaired fetal growth also impair lung and airway development and possibly 
also postnatal programming in line with the DOHAD principle. 
However being large for gestational age may also be a risk factor for impaired lung func-
tion. Infants with a high birth weight (>4.5kg) enrolled in a population based Canadian 
cohort, had an increased risk of hospital visits for asthma in the first 10 years of life134 
suggesting that being overweight at birth may affect lung mechanics in early life.  In ad-
dition postnatal weight gain has been negatively associated with normal lung function in 
early life. Increased postnatal weight gain has been associated with lower forced expi-
ratory flows and lung volumes30 33 135 This increased postnatal weight gain has also been 
associated with increased wheezing and doctor diagnosed asthma in children up to three 
years of age.135 In a meta-analysis of 31 birth cohort studies including over 147 000 in-
fants followed to school age, increased postnatal weight gain increased risk of preschool 
wheeze and doctor diagnosed asthma at school age.136 This suggests a sustained effect 
of weight gain on lung mechanics through childhood and is a potentially preventable risk 
factor for impaired lung function. 
4.2 Prematurity
Prematurity is associated with decreased lung function at birth with persistence through 
early life and is associated with low lung function and chronic respiratory illness in older 
children and adults.137-139 The prematurity-associated reduced lung function is thought to 
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be due to a combination of immature lung development (alveolarisation, vascular) and 
postnatal events and exposures such as oxygen therapy and ventilation induced lung 
damage. Even in infants without a history of neonatal respiratory disease however, lung 
growth is reduced, independent of birthweight.139 Lung function abnormalities in very 
premature infants <32 weeks are well documented.139-143 In addition late preterm infants 
(33-36 weeks gestation) have also been shown to have reduced early life lung function 
compared to full term infants. 144 145 Strategies to prevent preterm birth, judicious use of 
corticosteroid therapy and surfactant and optimising postnatal care are important strate-
gies to reduce early life lung function impairment. 
4.3 Maternal smoking during pregnancy
One of the most consistent and much studied prenatal exposures is maternal smoking 
during pregnancy (MSIP), which has convincingly shown adverse effects on early lung 
growth and function in both human and animal models.36 Many studies have tested lung 
function at a few weeks of age and hence described the effect of both in utero and early 
life passive smoke exposure.60 74 85 86 146 147 However, studies assessing in utero expo-
sure alone with lung function at birth have also shown significant impairments of lung 
function.76 77 148 This adverse effect occurs not just during exposure in the last months 
of pregnancy but also with early pregnancy exposure, as has been shown in studies in 
preterm infants. 77  
The effect of maternal smoking on lung function is independent of reduced somatic 
growth. Adjusted forced expiratory flows are reduced in infants’ whose mothers smoked 
during pregnancy. This includes reduced maximal expired flow at functional residual ca-
pacity (VmaxFRC)
26 77 149 and forced expiratory flows when 75% of forced vital capacity is 
expired (FEF75).
87 146 150 These are measures of peripheral airway obstruction. Effects 
of maternal smoking on respiratory system resistance and compliance have also been 
described. Lodrup-Carlsen et al testing a large cohort of healthy infants using the single 
breath occlusion technique, found a lower compliance in female infants whose mothers 
smoked during pregnancy compared to those whose mothers did not.74 Similarly in an 
English cohort of healthy full-term infants tested at 2.5 days of life, infants exposed to 
MSIP had reduced compliance.148 Others have found no effect of MSIP on Crs but a slight 
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increase in R.60 93 Measurement of passive respiratory mechanics may be a less sensi-
tive measure of smoking effect on lung function than the forced expiratory maneuvers, 
but taken together support the findings of animal studies describing altered airway devel-
opment with lung hypoplasia in nicotine exposed fetuses.151 152 
Tidal breathing measures have also been used to assess the impact of MSIP on in-
fant lung development. The most reported measure is the ratio of the time to peak tidal 
expiratory flow over total expiratory time (tPTEF/tE). Stick et al assessed lung function in 
the first few days of life (mean 62 hours) prior to discharge from hospital to determine 
any effect of in utero smoke exposure. They found the tPTEF/tE was reduced in smoke 
exposed infants and that the effect was stronger in mothers who smoke >10 cigarettes 
per day, suggesting a dose effect.76 Reduced tPTEF/tE has also been found in other cohorts 
investigating in utero smoke exposure77 and MSIP together with early postnatal passive 
smoke exposure.74 This ratio may reflect a smaller airway caliber. However the tPTEF/tE is 
the result of a complex interaction between mechanical and neurological control and an 
altered ratio could reflect either or both mechanically reduced airway caliber and altered 
control of breathing.153 154 In addition to effects on lung mechanics, infant respiratory con-
trol may also be affected by MSIP – with blunted response to hypoxia and increased risk 
of sudden infant death.155-157 Hence the effect seen in reduced tPTEF/tE may reflect both the 
structural effect of smoke exposure on airway development and the modified control as 
evidenced by altered response to hypoxia. 
Taken together in utero smoke exposure appears to cause structural changes in the 
developing lung, which persist. Exposed babies have smaller airways at birth and hence 
are more likely to wheeze with inter-current infections. They may have altered respons-
es to hypoxia making them vulnerable to poor outcome with respiratory tract infections 
and increased risk of sudden infant death. Post-natal exposure to household cigarette 
smoke is an independent risk factor for impaired lung function in most studies.59 85 158 and 
may also exaggerate the effects of in utero exposure and predispose to more frequent, 
severe early life infections.
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4.4 Maternal asthma and/or atopy
A family history of asthma and/or atopy has been investigated as a predictor of early life 
lung function. A maternal history of asthma is known to increase the risk of wheezing 
episodes in early life, either through inherited vulnerability to bronchial hyper-respon-
siveness,85 reduced low lung function at birth60 or altered responses to infectious allergen 
exposure.126 Martinez et al described the early life patterns of wheeze in a longitudinal 
cohort of USA children followed from birth through to six years and correlated baseline 
lung function, serum IgE, maternal asthma and frequency of wheezing episodes through 
the first 22 years of life.20 159 They found that a maternal history of asthma was not associ-
ated with low lung function in early life, but that children of asthmatic mothers were more 
likely to have a history of persistent wheezing through the first years of life and reduced 
lung function at six years.159 However, others have noted an association of family history 
of asthma and low lung function at birth.60 76 In 101 infants followed in a UK prospective 
birth cohort and who had lung function before 13 weeks of age, a family history of asthma 
was associated with decreased specific airway conductance (1.98 s-1.hPa-1 vs. 2.6 (1.0) 
s-1.hPa-1; 0<0.05).60 In the Western Australia Pregnancy Cohort study, a family history of 
asthma was associated with a decreased tPTEF/tE at one month in 461 infants.
76 Others 
have noted an association of familial asthma and bronchial hyper-responsiveness.160 
Young et al assessed bronchial hyper-responsiveness (BHR) with histamine challenge 
at one month of age and found infants with a family history of asthma had an increased 
BHR compared to infants who did not have this history (PC40 0.78 g.L-1 vs. PC40 2.78 
g.L-1 respectively).160 Infants born to atopic parents and who have low lung function in 
early life have an increased risk of wheezing illness and asthma.26 88 Elevated levels of 
exhaled nitric oxide (eNO) are associated with atopy. Latzin et al measured eNO in in-
fants in a Swiss birth cohort soon after birth and prospectively followed them for respira-
tory symptoms in early life.121 Infants of atopic mothers with high eNO levels were more 
likely to wheeze than those who did not have raised eNO. This suggests that there is 
early and pre-symptomatic activation of atopy associated airway inflammation in infants 
with a genetic predisposition. In at risk children (both parents atopic) prospectively fol-
lowed in the Copenhagen Prospective Study on Asthma in Childhood (COPSAC) study, 
those that were subsequently diagnosed with asthma at 7 years had reduced expiratory 
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forced expiratory flow at 50% forced vital capacity and BHR as neonates compared to at 
risk infants who did not go on to develop early childhood asthma.88 
In summary, maternal history of asthma and atopy is associated with increased risk of 
wheeze in later life. Although it is associated in some studies with reduced early lung 
function this association becomes more consistent in later childhood with effect increas-
ing over time.88 Taken together this suggests that maternal atopy infers an inherited risk 
for bronchial hyper-responsiveness and wheeze, which becomes more apparent later in 
childhood.  The impact of asthma and atopy on early lung function in African populations 
has not been studied.
4.5 Gender
Previous studies have shown male infants to have reduced early life lung function as 
compared to female infants.23 85 158 161-163 These differences include higher respiratory 
system resistance, lower compliance and reduced expiratory flows in male compared 
to female infants. Hanrahan et al. investigated healthy infants at 2 to 6 weeks with the 
SOT and reported that male infants had a significantly higher R (0.083 vs. 0.079 cm-
H2O.s.mL
-1; p=0.003) but a non-significantly lower C (5.4 vs. 5.54 mL.cmH2O
-1; p=0.37) 
compared to female infants.158 Stocks et al. tested preterm infants at 5 to 39 days with 
the SOT and multiple occlusion technique; female infants had a non-statistically signif-
icant lower resistance than males (95%CI: -2.93; p=0.2), and significantly higher time 
to peak expiratory flow over total expiratory time.161 This is consistent with other reports 
of low lung function in male infants77 85 158 163 164, suggesting that male infants may have 
a less mature respiratory system at birth with smaller airways and functional residual 
capacity compared to female infants. This difference in lung function between male and 
female infants tracks through the first year of life.85 Although not all studies have shown 
male sex to impact normal lung growth, responses to post-natal insults are modified by 
sex.25 This lower early lung function in boys may be one factor contributing to the higher 
rate of respiratory disease amongst boys in childhood.165
4.6 Ethnicity
Ethnic differences in lung function in older children and adults are well established. Peo-
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ple of Black African ethnicity having lower forced volumes and expiratory flows compared 
to Caucasians after correcting for anthropometry and sex, a difference thought to be relat-
ed to trunk leg ratio as lung function based on sitting height is similar between races.166 167 
Ethnic differences in infant lung function have been previously reported.77 107 164 168 169 
Full-term Black African infants have a lower nasal resistance169 and increased airway 
conductance107 compared to Caucasian infants, which may be related to differences in 
anatomical structure. Prolongation of tPTEF/tE  
77 164 and higher forced expiratory flows77 in 
Black Afro-Caribbean compared to Caucasian European preterm infants has also been 
previously described, suggesting a different early pattern of breathing in African infants. 
Ethnic differences in lung function at birth and later in life, may relate to a number of fac-
tors including anatomical structure and alterations in maturation of respiratory control. 
Although early life differences may be transient, defining the effect of ethnic group on a 
population and taking this into account when interpreting lung function measures is im-
portant. There is very little lung function data published for any Southern African infant or 
paediatric populations, hence collecting such information will add to our understanding 
of normal lung growth in these populations and how this may differ to what is already 
known in other populations.
4.6 Air pollution
There are very few data on the impact of antenatal exposure to air pollution on infant lung 
function. Maternal exposure during pregnancy to particulate matter less than 10  microns 
(PM10), nitrogen dioxide and ozone has been associated with increased minute ventila-
tion and exhaled nitric oxide in the infants.38 Given the association of air pollution with 
respiratory disease, understanding the impact of antenatal exposure on early lung func-
tion is an important area requiring further research.170 Postnatal exposure to air pollution 
has been associated with decreased lung function in children171 and chronic exposure 
with decreased lung growth.172 173 This includes exposure to nitrogen dioxide, particulate 
matter, ozone and volatile organic compounds including benzene.171 172 Recent evidence 
suggests that reducing exposure to air pollutants can ameliorate the impact on lung 
growth,174 highlighting the need for public health interventions targeting air pollution par-
ticularly in high risk communities.
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4.7 Wheezing and respiratory tract infections
Children with wheeze, with or without respiratory tract infections, in the first few years 
of life have lower lung function at one year and two years, but this effect appears to be 
mediated by pre-existing low lung function.27 59 67 175 Longitudinal studies of infant lung 
function have shown low lung function to precede wheezing episodes.23 42 176 21 25 Lung 
function in infants that wheeze, tracks during the first few years and wheezing episodes 
do not appear to impair normal lung growth.59 67 
The association between early life lower respiratory tract infections (LRTI) and subse-
quent decreased lung function and chronic respiratory symptoms has been less well 
studied.  LRTI have the potential to cause lung damage that may lead to temporary or 
permanent alterations in lung function. Several retrospective studies have suggested 
that a documented LRTI in infancy and childhood increases the risk of chronic respi-
ratory symptoms and reduced lung function in later childhood and adulthood.10 11 177-181 
Viral respiratory infections, particularly rhinovirus, in early life are associated with the 
later development of asthma.182 183 However, none of these studies included baseline 
lung function measures and hence these studies were unable to distinguish between 
the respiratory infections or pre-existing respiratory disease vulnerability as the cause 
of decreased lung function or chronic respiratory disease. Two groups have prospec-
tively assessed the impact of early life respiratory tract infections on later lung function. 
Castro-Rodriguez et al investigated 133 children longitudinally with lung function at two 
months and again at 11 years, collecting information on inter-current respiratory tract 
infections, both those with and without radiological pneumonia.184 In this study children 
with respiratory tract infections without radiologically defined pneumonia had reduced 
premorbid lung function at two months, which persisted to 11 years. Children with ra-
diologically confirmed pneumonia have reduced lung function at 11 years, but only eight 
of these children had baseline lung function measured and hence they were not able 
to accurately assess the role baseline lung function played in risk for pneumonia or 
subsequent lung function deficit.184 The Oslo birth cohort, Environment and Childhood 
Asthma study, prospectively followed a cohort of 607 infants with lung function at birth, 
two years and ten years of age, recording LRTI during the first two years of life.78 This 
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study suggests that LRTI in the first two years of life do not impact on normal lung growth 
between birth and ten years of age, nor the lung function achieved at ten years. The LRTI 
incidence in this cohort during the first two years was 22% and the majority of infections 
(56%) were bronchiolitis episodes. 
5. Determinants of lung function in the African context
There have been no studies investigating lung function growth in African children. Given 
the importance of early lung health on subsequent lung disease there is an urgent need 
for research on lung function of African infants. 
Several factors are important to the African context including HIV exposure, indoor air 
pollution and early life LRTI. HIV infection is well known to cause acute and chronic re-
spiratory disease.185 Exposure, but not infection, to HIV in utero could affect lung growth 
through the direct effects of the HIV virus, consequences of immune suppression or 
exposure to antiretroviral therapy. Prevention of mother to child transmission of HIV in-
fection includes antiretroviral therapy (ART) taken by the mother throughout pregnancy. 
There are no published data comparing lung function in HIV exposed uninfected and HIV 
unexposed infants. Exposure to in utero ART in HIV exposed uninfected infants is asso-
ciated with anaemia, neutropenia, thrombocytopenia, mitochondrial abnormalities and 
cardiac function effects (increased fractional shortening and decreased left ventricular 
mass).186 187 It is possible exposure to HIV in utero may impact lung function and growth 
and impact respiratory health in exposed infants. The impact of early life LRTI on normal 
lung growth and subsequent lung function is also not clear. Given the high incidence of 
childhood LRTI and chronic respiratory disease in Africa, this is important to investigate. 
Exposure to air pollutants is likely to be very different to that of the infant lung function 
cohorts already studied. Africa has a high rate of biomass fuel use.188 Overcrowding 
and high density living increase potential for high exposure to air pollution and cigarette 
smoking is increasing in low income households.189 Understanding the contribution of 
local environmental exposures on lung health is important.
In summary many factors known to impact early lung function and increase risk of rep-
siratory disease are common in Africa. Better understanding the impact of these factors 
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in African infants will improve our ability to develop appropriate strategies to prevent or 
ameliorate damage to lung growth and reduce risk of respiratory disease. 
Aims
The overall aim of this thesis is to describe lung function in South African infants from 
six weeks to one year and to investigate the impact of prenatal and early environmental 
exposures on lung function in infancy.
Specific aims: 
1. To describe lung function in African infants and to develop normative data ranges at 
six weeks of age for this population. 
2. To investigate the impact of antenatal and early life exposures on lung function at 
six weeks of age. 
3. To longitudinally measure lung function at six weeks and one year in South African 
infants.
4. To investigate the impact of nutritional, immunological and environmental factors; 
infant lung function and intercurrent lower respiratory tract infections during the first 
year of life on lung function outcomes at one year of age.
Hypotheses 
1. Reduced infant lung function (six weeks of age) is associated with reduced lung 
function at one year.
2. Antenatal and early post-natal exposures including nutritional factors (poor growth 
and/or obesity), immunological factors (atopy, or acquired immune deficiency), en-
vironmental factors (household air pollution, including smoking) and/or infective 
factors (early postnatal respiratory infections) alter lung structure in utero and/or in 
early life and are associated with altered lung function outcomes in early infancy (six 
weeks of age and at one year of age) 
3. Lung function tracks from six weeks to one year of age.
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The chapters of the thesis will address the following:
1. Establishing infant lung function testing in a South African peri-urban setting: de-
scription of study methodology.
2. Assessing the feasibility of a novel measure of infant respiratory impedance.
3. Describing lung function in African children; and development of normative data 
ranges at six weeks of age for this population. 
4. Investigating the impact of antenatal and early life determinants on early infant lung 
function (six weeks of age). 
5. Longitudinal investigation of lung function from six weeks to one year of age and 
investigating the impact of nutritional, immunological and environmental factors; in-
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Background: The burden of childhood respiratory illness is large in low and middle in-
come countries. Infant lung function testing may provide useful information about lung 
growth and susceptibility to respiratory disease. However, ILF has not been widely avail-
able in low and middle income settings where the greatest burden of childhood respira-
tory disease occurs.
Aim: To implement and evaluate a pilot study of infant lung function testing in a semi-ru-
ral setting in South Africa. 
Method: Infant lung function testing was established at a community hospital in South 
Africa. All measures were done in unsedated infants during sleep. Measurements, made 
with the infant quietly breathing through a face mask and bacterial filter, included tidal 
breathing (TBFVL), exhaled nitric oxide (eNO) and sulphur hexafluoride multiple breath 
washout (MBW) measures using an ultrasonic flow meter and chemoluminescent NO 
analyzer.
Results: Twenty infants, mean age of 7.7 (SD 2.9) weeks were tested; 8 (40%) were 
Black African and 12 (60%) were mixed race. Five (25%) infants were preterm. There 
were 19 (95%) successful TBFVL and NO tests and 18 (90%) successful MBW tests. 
The mean tidal volume was 30.5 ml (SD 5.9), respiratory rate 50.2 breaths per minute 
(SD 8.7) and eNO 10.4 ppb (SD 7.3). The mean MBW measures were: functional resid-
ual capacity 71 ml (SD 13) and the lung clearance index 7.6 (SD 0.5). The intra-subject 
coefficients of variations of lung function measures were similar to published normative 
data for Caucasian European infants. 
Conclusion: In this study we demonstrate that unsedated infant lung function measures 
of tidal breathing, MBW and eNO are feasible in a semi-rural African setting with rates 
comparable to those reported from high income countries. 
Keywords
Respiratory function test, South Africa, paediatric
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Background
Lung development is incomplete at birth with much lung growth occurring during the first 
few years of life. Assessment of lung function longitudinally from birth may offer valuable 
information about the true burden, determinants and outcomes of low lung function in 
early life. An objective measure of lung function is necessary to achieve this. Until recent-
ly infant lung function (ILF) testing has been largely restricted to isolated research insti-
tutions using custom made equipment. This made it difficult to compare results reducing 
generalizability among sites. Equipment was often bulky, testing moderately invasive 
and almost exclusively done under sedation, which limited its use in well infants and par-
ticularly its use in community settings. Recent advances in technology, standardisation 
of ILF measurement equipment and techniques through international expert collabora-
tion has allowed the development of tests that are easily done in unsedated infants and 
have made ILF a more accessible and useful tool.1 2 ILF is now routinely used in high 
income countries as an epidemiological and clinical tool.3-6  
The burden of acute and chronic respiratory disease is high in low and middle income 
countries (LMICs). Respiratory illness is a leading cause of early childhood death in 
LMICs.7 8 In addition chronic respiratory illness is increasingly common and associated 
with a substantial burden of disease in African children and indeed globally.9 Developing 
respiratory function measures that can be used in these settings to assess determinants 
of respiratory disease is desirable. 
However little is known about ILF in African children, a region with one of the highest 
burdens of childhood respiratory disease.9 10 Infant lung function has not been previously 
undertaken in South Africa or any other African setting. We hypothesised that unsedated 
infant lung function measures, including tidal breathing, exhaled nitric oxide and multiple 
breath washout testing, can be safely and successfully undertaken in a semi-rural setting 
in the Western Cape, South Africa. Hence we aimed to demonstrate feasibility of ILF in 
this setting and to provide pilot data for a larger birth cohort study, the Drakenstein Child 




The study was approved by the Faculty of Health Sciences, Human Research Ethics 
Committee, University of Cape Town (401/2009) and by the Western Cape Provincial 
Health Research committee. Written informed parental consent was obtained in the first 
language of the parent.
Site Description
Infant lung function testing was established at Paarl hospital, a community hospital lo-
cated in the semi-rural Drakenstein region. The hospital serves a low socio-economic 
community of approximately 200 000 people; all births in the public sector (approximate-
ly 90% of all births in the area) occur at this hospital.   
Participants
Infants born between March and June 2012 at Paarl hospital, South Africa were eligible 
for enrolment. Infants born during enrolment period, who were healthy and whose par-
ents gave consent were eligible for inclusion. Any infant with an acute or chronic illness 
was not included. Infant testing was booked for 6 to 10 weeks of age and was delayed 
until at least 2 weeks after any acute respiratory infection.
Infrastructure development and training
An international collaboration was established between paediatric pulmonologists in 
South Africa and ILF specialists in Australia. The local investigator and respiratory tech-
nologist were trained in Perth, Australia during Nov-Dec 2011 in ILF testing techniques. 
Training included the set up, calibration, data collection and analysis of the tidal breathing 
measures (TBFVL), exhaled nitric oxide (eNO) and multiple breath washout (MBW) tech-
niques. A second technologist was trained on-site during the set up period. Standard op-
erating procedures were established with oversight from the international collaborators, 
who also provided on-going supervision and training through regular teleconference. 
During this period early studies were over-read by the experts in Perth with feedback to 
the study team. The equipment used was the EcoMedics ExhalyzerD with ultrasonic flow 
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meter and CLD88 NO chemoluminescent analyser (EcoMedics, Duernten, Switzerland). 
The company provided an initial introduction to the equipment during the set up; the local 
team was then assisted through email and teleconference communication during the first 
months for troubleshooting. Supply chains for consumables including SF6 testing and 
NO calibration gas mixtures were successfully established.
Infant Lung Function
Infant lung function was tested between 1 to 3 months of age. All tests were done by the 
same testing team, which consisted of a trained respiratory technologist and a profes-
sional nurse, supervised by a paediatric pulmonologist. Testing was measured in unse-
dated infants during behaviourally defined quiet natural sleep.11 If the child woke during 
a measurement the child was settled and testing restarted when the child was in quiet 
sleep. Measurements were taken with infants lying supine with their head in the midline 
using a size 0 round infant silicone placed over the nose and mouth. The effective dead 
space of the mask (5mL) was determined as the water displacement volume of the mask 
on a curved surfaced and applying similar pressure to the mask as used during an actual 
test. The water displacement volume was then halved to determine the effective mask 
deadspace as recommended previously 1 12 and as published by our group.13 14 Testing 
was performed on commercially available equipment that conformed to the ATS/ERS ILF 
equipment standards.1 Flow was measured using a commercially available ultrasonic 
flow meter (Ecomedics AG, Duernten Switzerland). A dead space reducer (size 1) was 
used to reduce the internal dead space of the flow meter to 1.2 ml. A disposable bacterial 
filter (SpiretteTM, EcoMedics AG, Duernten, Switzerland) surrounded the dead space 
reducer. A bias flow of 200 mL·s-1 was used. During data collection, flow-volume loops 
were observed to ensure there was no leak. Data were recorded at ambient temperature, 
pressure and saturation with flow and volume being converted to body temperature and 
pressure, saturated conditions during data analysis. Leak was defined as volume drift of 
>3ml.s-1 and data excluded in these cases. Measurements were collected in the follow-
ing order: TBFVL and simultaneous eNO for 90 seconds, followed by three acceptable 
MBW measurements where possible. Data analysis, detailed for each test below, was 
independently repeated by experts in Perth to assure quality control. Test analysis was 
67
blinded with neither of the two sites, Perth and Drakenstein, having reference to the other 
score. 
Tidal breathing recordings (TBFVL) were obtained during quiet tidal breathing at least 
30 seconds after initial mask placement. Recordings were analysed if >30 consecutive 
regular breaths of tidal breathing were recorded during a 90 second epoch and accord-
ing to international guidelines.15 Mean tidal breathing measures were calculated using 
analysis software (Wbreath v3.2.0, Ndd Medizintechnik AG, Zurich, Switzerland) as re-
ported previously.16 17 Outcome parameters included respiratory rate, tidal volume, min-
ute ventilation, mean tidal inspiratory flow, mean tidal expiratory flow and the ratio of time 
to peak tidal expiratory flow /expiratory time as a description of the shape of the tidal 
breathing flow volume loop.
Exhaled nitric oxide (eNO) measurements were recorded simultaneously with the 
TBFVL and according to international guidelines and as previously published by our 
group.17 18 Exhaled NO was an online measurement with a rapid-response, chemolumi-
nescence analyser (CLD 88 Exhalyzer, Ecomedics AG, Duernten, Switzerland). Testing 
used NO free air for inspiration avoiding contamination from ambient NO. Exhaled NO 
was calculated breath by breath during the third quartile of expiration and the mean eNO 
calculated from a minimum of 30 recorded breaths using the analysis software (Wbreath 
v3.2.0, Ndd Medizintechnik AG, Zurich, Switzerland). The outcome parameters recorded 
included the eNO and the NO output (eNO x corresponding expiratory flow).
Multiple breath washout (MBW) testing was performed using 4% SF6 as a tracer gas and 
ultrasonic flow meter (Spiroson©, Ecomedics AG, Duernten, Switzerland) with acquisi-
tion and analysis software (Wbreath v3.2.0, Ndd Medizintechnik AG, Zurich, Switzer-
land) as reported by our group 13 and in accordance with recent recommendation for the 
measurement of MBW.19 The washout period began after a ten breath equilibrium period 
was obtained at the end of the tracer gas wash in. The washout continued until the trac-
er gas was eliminated from the lungs. The outcome parameters included the functional 
residual capacity (FRC) and the lung clearance index (LCI; cumulative expired volume/
FRC) and moment ratios (M1/M0 and M2/M0). The recordings were defined as accept-
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able for analysis if they occurred during quiet sleep with no sighs within 10 breaths of the 
wash-in plateau or 10 breaths after the SF6 concentration has returned to baseline. The 
process was repeated to obtain three successful recordings. If the child woke testing was 
restarted when infant went back to sleep, provided the parent was happy to wait. Anal-
ysis of the recordings using the analysis software (Wbreath v3.2.0, Ndd Medizintechnik 
AG, Zurich, Switzerland), included the use of optimised temperature and deadspace 
model.16 Flow and volume were converted to body temperature and pressure, saturated 
conditions during data analysis. The mean FRC and LCI value of the 3 tests was report-
ed or the mean of 2 tests if the mean was within 10% of the lower value. 
Statistical analysis
Descriptive statistics were performed using STATA 11 for windows (STATA Corporation, 
College Station, USA). Data are presented as mean and standard deviation (SD), me-
dian and interquartile range (IQR) and the 95% limits of agreement, which was defined 
as the mean difference ± 1.96 SD. The intra-subject coefficient of variation (CV) was 
calculated as the ratio of each parameter standard deviation over the parameters mean 
per study participant. For FRC and LCI this was calculated from the mean and standard 
deviation of the MBW tests collected. The agreement between observers’ results from 
the two sites was presented as the mean difference and SD, and minimum and maxi-
mum values.
Results
The demographics of included infants are summarised in Table 1.Twenty infants with a 
mean age of 7.7 (range 3.4 to 14) weeks consented for participation.  Five (25%) were 
preterm, defined as born before 37 weeks post gestational age. Of the infants tested 
one TBFVL and one eNO test was excluded due to poor quality trace on analysis (less 
than 30 regular breaths selected), thus there were 19 (95%) successful TBFVL and eNO 
tests. Two MBW tests were excluded as one child woke up and could not complete the 
test and in the second the mean of the two tests obtained was not within 10% of the lower 
value; there were therefore 18 (90%) successful MBW tests. The median time taken per 
infant test was 22 min (range 6 to 64). Six (30%) infants woke during testing and had to 
be settled for a second measurement. One infant did not sleep and required rebooking 
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on another day to complete testing. The median length of lung function visit, including 
waiting time for infants to sleep was 159 min (range: 27 to 320).
Tidal breathing and MBW results are shown in Table 2. The mean (SD) difference be-
tween the blinded analyses of the Perth and Drakenstein sites for FRC in mL was 0.17 
(0.5), range: 0 to 2.2 and LCI 0.05 (0.1); range: 0 to 0.5. The intra-subject coefficient of 
variation (CV) demonstrates the variability for each outcome and ranges from 6.5% for 
minute ventilation (V’E) to 19.7% for the ratio of time to peak tidal expiratory flow over 
the total expiratory time (tPTEF/tE). 
The multiple breath washout test results, table 2, include measures of lung volume, the 
functional residual capacity (FRC) and measures of ventilation inhomogeneity the lung 
clearance index (LCI) and moment ratios. The intra-subject CV was 6.8% for the FRC 
and 3.6% for the LCI. The exhaled nitric oxide results, table 2, include exhaled NO and 
NO output.
Discussion
This study describes the successful implementation of an ILF testing site in a semi-rural 
setting in South Africa. This is the first time ILF testing, predominantly used in specialised 
centres in high income settings, has been used in Africa. 
The success rates for testing were similar to those reported by Fuch’s et al20, who re-
corded an 85% testing success for TBFVL measures, 76% for eNO and 59% for MBW 
testing in 342 healthy unsedated European infants at 4 to 9 weeks of age. Although 
the equipment and testing procedures used in this study were similar, the Fuchs study 
used a longer tidal breathing epoch of 100, compared to 30, consecutive regular breaths 
during quiet sleep. This would have prolonged testing and possibly reduced the chance 
of successfully recording all measures before infants woke.
Successful implementation depended on several key factors.  These included close and 
ongoing collaboration with international experts experienced in ILF testing, initial training 
in an experienced laboratory, back up technical support from the supplier of the equip-
ment, sufficient resources for equipment, training and staffing, a defined research space 
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and dedicated, well trained staff onsite. The initial training of a local technologist in the 
overseas ILF centre allowed for the training of further local technologists. This collabora-
tion ensured strict supervision of data quality and allowed double analysis of data. This 
collaborative work is possible with standard internet connectivity and did not necessarily 
require teleconference facility. 
The median time of testing during this study was 22 minutes (IQR 6; 64). This only in-
cluded active testing time. Six (30%) of the infants required resettling and a second at-
tempt at testing hence the total visit time [median (range): 159 min (27; 320)] was long in 
these infants. Thus successful completion of unsedated infant lung function testing can 
be time consuming. Importantly, no sedation was used, thus the measurements reflect 
physiological lung volumes during sleep. Furthermore, this makes the procedure espe-
cially safe and reduced the need for post test observation and monitoring. 
The results of the testing were comparable to the normative values for European infants 
published by Fuchs et al (Table 3) 20. This comparison is however limited by the pilot 
studies small sample size, and should be confirmed in a larger cohort from a similar 
South African community. In addition the pilot cohort included infants born prematurely, 
a known risk factor for early low lung function.21 However none of our infants were born 
less than 33 weeks gestation and mean gestation was 37 weeks. Twenty five percent of 
infants’ mothers smoked during pregnancy. Maternal smoking is a known risk factor for 
low lung function at birth.22 23 The results of this study cannot be used to inform normative 
ranges for African children given the small sample size of this pilot and the inclusion of 
infants at risk of low lung function.
The results had acceptable variability, as expressed by the intra-subject CV, supporting 
the feasibility of the proposed larger project. In the tidal breathing measures the CV for 
each parameter was less than 10% except for the tPTEF/tE, which was 19.7%. This is con-
sistent with previously published results of similar testing in unsedated infants.20 24 The 
mean FRC in this study 70.7 (SD 13) was lower than the European study, 102 (SD 16). 
The LCI was higher, 7.6 (SD 0.5) compared to 6.7 (SD 0.6) in the European study. The 
infants in the South African cohort were an average of 2 weeks older than the European 
71
cohort. The difference in FRC and LCI may relate to the different ethnicity or socio-eco-
nomic status of this group, factors that have been previously reported to effect lung 
function measurements in young children.25 26 A larger cohort is needed to confirm this 
and investigate possible associations. The mean eNO in this study of 10.4 (SD7.3) was 
lower than the 14.3 (SD 6) reported by Fuchs et al. However the sample size is too small 
to make meaningful comparisons and further study with a larger sample is required.
In conclusion, this pilot study has described the development of technical and clinical ca-
pacity in ILF testing in a LMIC setting. This study provides reliable data for supporting the 
use of these measures in a prospective birth cohort study, the Drakenstein Child Lung 
Health Study. This technique has the potential to be a useful tool in obtaining valuable 
information on early lung growth, function and the development of acute and chronic lung 
diseases in children living in high burden settings including Africa. 
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Table 1 Demographics of infants (n=20)
Characteristic at study date Mean (SD) Med (min; max)
Age (weeks)1 7.7 (2.9) 6.6 (3.4; 14)
Weight (kg) 4.6 (0.99) 4.5 (3; 6.2)
Height (cm) 51.5 (3.1) 50.5 (47; 57)
Time taken for testing (min) 23 (12) 22 (6; 64)
Gestational age at birth (weeks) 37 (1.8) 37 (33; 39)
N (%)
Maternal smoking in pregnancy 5 (25)
Female gender 13 (65)
Ethnicity
   Black African 8 (40)
   Mixed race 12 (60)
1 Age corrected to 37 week gestation for preterm infants
Table 2  Tidal breathing, multiple breath washout and exhaled nitric  
oxide measurements
Tidal breathing Number 
n






Tidal volume ml 19 30.5 (5.8) 30.2 (25.3; 34.4) 18.9 - 42.1 6.8 (6; 7.9)
Respiratory rate 
breaths per min












1 19 37 (11.5) 35 (27; 44.8) 7.46 – 34.26 19.7 (15.6; 25.2)
MTIF2 19 54.8 (10.2) 54.3 (50; 57.3) 34.9 – 74.7 6.6 (5.4; 10)











FRC5 ml 18 70.7 (13) 66.3 (61; 83) 45.2 - 96.2 6.8 (4.5; 8.8)
LCI6 18 7.6 (0.5) 7.5 (7.3; 7.8) 6.6 – 8.6 3.6 (1.6; 6.4)
Moment ratio 
m1/m0
18 1.5 (0.1) 1.5 (1.3; 1.6) 1.3- 1.7
Moment ratio 
m2/m0











NO ppb 19 10.4 (7.3) 9.7 (3.4; 17.2) -4 – 24.7 4.2 (3.3; 5.5)
NO output mcl/s 19 7.8 (2.2) 7.2 (6.2; 9.1) 3.5 – 12.1 2.3 (0.8;3)
1Ratio of time to peak tidal expiratory flow over total expiratory time 2Mean tidal inspiratory flow 3Mean tidal 
expiratory flow 4Coefficient of variation, 5Functional residual capacity 6Lung clearance index
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Table 3 Drakenstein infant lung function compared to European birth cohort




Mean (SD) Median (IQR) 
intra-subject 
CV5




N successful test (%)
19 (95) 285 (96) 
Tidal volume ml, mean (SD) 30.5 (5.8) 6.8 (6; 7.9) 32.4 (5.5) 8.6 (7.1; 10.8)
Respiratory rate breaths per 
min, mean (SD) 
49.4 (8.4) 7.7 (6.5; 9.3) 45.2 (10.5) 9.1 (7.4; 11.3)




6.5 (4.6; 8.3) 1420 (277) 7.5 (6.1; 10.1)
PTEF/TE
1 37 (11.5) 19.7 (15.6; 
25.2)
34.8 (10.7) 23.8 
(20.2;28.4)
Multiple breath washout 
N successful tests (%)
18 (90) 201 (68) 
FRC2 ml, mean(SD) 70.7 (13) 6.8 (4.5; 8.8) 102 (16) 6.3 (4.4; 8.3)
LCI3 7.6 (0.5) 3.6 (1.6; 6.4) 6.75 (0.6) 5.8 (3.6; 8.0)
Exhaled nitric oxide 
N successful tests (%)
19 (95) 261 (88) 
NO4 ppb 10.4 (7.3) 4.2 (3.3; 5.5) 14.3 (6) 10.3 (6.4; 
15.7)
NO output mcl/s 7.8 (2.2) 2.3 (0.8;3) 6.3 (2.5) 12.4 (8.9–
18.1)
1Ratio of time to peak tidal expiratory flow over total expiratory time, 2Functional residual capacity, 3Lung 
clearance index, 4Nitric oxide, 5Coefficient of variation
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Unsedated South-African Infants: effects of 
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Abstract
Background: Non-invasive techniques for measuring lung mechanics in infants are 
needed for a better understanding of lung growth and function and to study the effects 
of prenatal factors on subsequent lung growth in healthy infants. The forced oscillation 
technique requires minimal co-operation from the individual, but has rarely been used in 
infants. 
Aim: To assess the use of the forced oscillation technique to measure the influence of 
antenatal exposures on respiratory mechanics in unsedated infants enrolled in a birth 
cohort study in Cape Town, South Africa.
Method: Healthy term infants were studied at 6-10 weeks of age using the forced os-
cillation technique. Respiratory impedance was measured in the frequency range 8-48 
Hz via a facemask during natural sleep. Respiratory system resistance, compliance and 
inertance were calculated from the impedance spectra.  
Results: Of 177 infants tested, successful measurements were obtained in 164 (93%). 
Median (25-75%) values for resistance, compliance and inertance were 50.2 (39.5-
60.6) cmH2O.s.L
-1, 0.78 (0.61-0.99) mL.cmH2O
-1 and 0.062 (0.050-0.086) cmH2O.s
2.L-1, 
respectively. As a group, male infants had 16% higher resistance (p=0.006) and 18% 
lower compliance (p=0.02) than females. Infants whose mothers smoked during preg-
nancy had a 19% lower compliance than infants not exposed to tobacco smoke during 
pregnancy (p=0.005). Neither maternal HIV infection nor ethnicity had a significant effect 
on respiratory mechanics. 
Conclusions: The forced oscillation technique is sensitive enough to demonstrate the 
effects of tobacco smoke exposure and sex in respiratory mechanics in healthy infants. 
This technique will facilitate assessing perinatal influences of lung function in infancy.
Keywords: respiratory function test, forced oscillation technique, respiratory compli-
ance, respiratory resistance, paediatric
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Introduction 
The assessment of lung mechanics in healthy infants offers the potential to better under-
stand normal lung growth and function, the determinants of early lung development and 
the relationship between lung function and respiratory disease. The forced oscillation 
technique (FOT) is a promising tool for measurement of lung function in infants as it is 
non-invasive, versatile and does not require controlled respiratory manoeuvres.1 More-
over, the small-amplitude oscillations are superimposed on spontaneous breathing, so 
measurements can be taken without interfering with normal respiration.
As a consequence of the non-invasive nature and the minimal demand for co-operation 
the FOT has gained popularity in paediatric lung function testing, and several coherent 
normative datasets have been published.2 3 However, its use in infancy has been sporad-
ic and largely confined to methodological validation studies,4-13 all using sedation except 
one.11 The development of a FOT approach that is able to non-invasively measure respi-
ratory system impedance (Zrs) in infants during natural sleep would provide the opportu-
nity to track the mechanical properties of the lung through the early years of life, a time of 
critical lung growth and development. In addition to the establishment of normative data 
in infancy, such a method would be useful in the studies on effects of prenatal factors that 
may impact on later respiratory health, such as maternal smoking and HIV infection, the 
prevalence of which is high in South African populations.
The purpose of this study was therefore to (i) describe the mechanics of the respiratory 
system using FOT in healthy unsedated infants and (ii) assess the impact of antenatal 
and early life factors on respiratory mechanics in infants from a large birth cohort study 
in a low- middle-income setting in South Africa.
Methods
Healthy infants aged 6 to 10 weeks enrolled in the Drakenstein Child Lung Health study, 
a birth cohort study established in a peri-urban area outside Cape Town, South Africa, 
were included in the study. The study population are low socioeconomic of African ances-
try, enrolled from health clinics serving two predominantly low socio-economic commu-
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nities. Details of the study population and setting are already published 14 and described 
in the online supporting information. The study was approved by the Faculty of Health 
Sciences, Human Research Ethics Committee, University of Cape Town (401/2009) and 
by the Western Cape Provincial Health Research Committee. Mothers gave informed, 
written consent in their first language for their infants to participate. 
Measurement of lung function
Zrs was measured with purpose-built FOT equipment (Fig. 1). A composite driving signal 
(frequencies: every 4 Hz between 8 and 48 Hz, pressure amplitude: <1 cmH2O) was 
generated by a loudspeaker and delivered to the infant through a wave-tube (internal 
diameter: 1 cm), an anti-bacterial filter (Humid-Vent, no. 19502, Teleflex Medical) and a 
facemask (Neonate crystal anaesthesia mask, no. 39170, Koo Asia, Hong Kong). The 
inlet and outlet pressures of the wave-tube were sensed by ICS transducers (Model 
33NA002D ICSensors, Miltipas, CA). Zrs was calculated as the load impedance on the 
tube,15 after corrections for the equipment impedances of the filter and the facemask. A 
pneumotachograph with a differential pressure transducer (ICS model 33NA002D) was 
attached to the wave-tube for monitoring the infant’s breathing pattern. The dead space 
of the equipment was continuously flushed by a bias flow of air at 2 L.min-1.
The measurements of Zrs were made during quiet sleep in the supine position, with the 
head supported in a neutral position. A minimum of 5 technically acceptable 30-s data 
epochs were collected. Recordings (or short segments of them) that contained breath 
holds, cries, irregular breathing or leaks around the facemask were excluded. Zrs spec-
tra were defined as reproducible if at least 3 of the spectra had Zrs magnitude values 
within 10% of each other. The individual Zrs spectra were evaluated by fitting a resis-
tance (R) – compliance (C) - inertance (I) model to the measured data and the results 
averaged (see the online supporting information for details). Resonance frequency (fres) 
was calculated as fres=1/(2π√CI). 
Collection of antenatal and early life data
Information regarding antenatal, birth and early life exposures and events were collect-
ed by questionnaires at scheduled study visits.16 Maternal smoking was confirmed by a 
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quantitative analysis of maternal urine cotinine, and all mothers underwent HIV testing at 
an antenatal visit and at birth; details of these tests are described in the online supporting 
information. 
Statistical analysis
Statistical analysis was performed using STATA 13 (STATA Corporation, College Station, 
Texas, USA). Data are presented as mean, standard deviation (SD), median and 25-
75% and 95% confidence intervals. The intra-subject coefficient of variation (CoV) was 
calculated as CoV=100SD/mean for each infant’s measurement. The relationships be-
tween anthropometric variables, prenatal/perinatal data and respiratory mechanics were 
examined using the Wilcoxon rank-sum test for independent samples and Spearman’s 
correlation analysis. A multivariate analysis examining the determinants of the Zrs pa-
rameters was undertaken, as detailed in the online supporting information. Differences 
at a p value of <0.05 were considered statistically significant.
Results
Of 219 infants tested, 42 infants who were born preterm or had previous pneumonia 
were excluded leaving 177 healthy infants; 164 (93%) of whom had acceptable data 
collected (see Fig. S1 in the online supporting information for exclusion categories). The 
demographic data of the 177 infants are shown in Table 1.  
The values of impedance parameters R, C, I and fres are summarized in Table 2. The 
intra-subject variability, represented by the median (25-75%) of the intra-individual CoV 
is also included. The Zrs parameters showed strong interdependences (see Fig. S2 in 
the online supporting information) with a negative correlation between C and R (r=-0.52; 
p<0.001), and positive correlation between I and R (r=0.57; p<0.001). 
The association of demographic factors and early life exposure and respiratory me-
chanical parameters measured with FOT are represented in Fig. 1. Male infants had 
10% higher R (53.2 [40.9-65.4] vs. 48.3 [37.2-58.8] cmH2O.s.L-1, p=0.005) and 17% 
lower C compared to female infants (0.72 [0.53-0.9] vs. 0.87 [0.69-1.08] mL.cmH2O-1, 
p=0.004); I and fres were similar in male and female infants. Infants whose mothers 
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smoked during pregnancy had a 21% lower C (0.71 [0.54-0.96] vs. 0.92 [0.80-1.20] 
mL.cmH2O-1, p=0.005) and 19% higher fres (24.6 [20.2-28.6] vs. 20.6 [18.3-23.2] Hz, 
p=0.007) compared to infants whose mothers did not smoke; with no difference between 
groups for R and I. Ethnicity and maternal HIV infection did not have a significant effect 
on any impedance measures. 
Results of the multivariate analysis of respiratory impedance determinants are displayed 
in Table S1 in the online supporting information. Adjusted for body size, ethnicity, sex and 
maternal HIV status, infants whose mothers smoked during pregnancy had 0.35 mL.cm-
H2O-1 lower C (95%CI -0.55 to -0.15, p=0.001) and 5 Hz higher fres (95%CI 1.9 to 8.1, 
p=0.002) compared to infants whose mothers did not smoke. Infants whose mothers 
were exposed to passive cigarette smoke during pregnancy also had reduced C, 0.23 
mL.cmH2O-1 lower (95%CI -0.41 to -0.04, p=0.016) and 2.9 Hz higher fres (95%CI 0.09 
to 5.7; p=0.04) compared to infants whose mothers were not exposed to passive smoke; 
although this effect was not as strong as the exposure to active maternal smoking. None 
of the exposures affected R or I measured with the FOT in the first few weeks of life.
Discussion
This is the first study to report the use of FOT in unsedated healthy term infants 1 to 3 
months of age. The success rate of 93% is higher than has been described in other infant 
cohorts reporting lung mechanics measurements in unsedated infants.17-20 The intra-test 
variability, ranging from 4% to 10% for resistance and from 7% to 22% for compliance, is 
similar to those reported in newborn infants 21 and older children 22 tested with the FOT. 
This suggests that FOT may be an appropriate lung function test for longitudinal studies 
through early childhood to adolescence. Further, this is the first investigation to report 
successful use of this technique in infants in a low–middle income setting, which carry a 
large burden of respiratory disease globally.23
Direct comparisons between resistance and compliance measured with FOT and that 
measured by other techniques in healthy unsedated infants such as the single occlusion 
technique (SOT),24-26 cannot be made. In particular, the compliance obtained from the 
FOT measurements at frequencies much higher than the spontaneous breathing rate 
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is approximately 5 times lower than the quasi-static compliance measured by the SOT.9 
26 Since the respiratory system resistance is less frequency-dependent, the values of R 
determined in the present study with the FOT are similar to those obtained with the SOT. 
The R measured with FOT was slightly higher than that measured in unsedated Euro-
pean infants using the interrupter technique,17 which may be partially explained by the 
differences in measurement technique used but may also reflect the different populations 
with differing risk of exposure in these studies. The FOT has the advantage of measuring 
Zrs during uninterrupted normal breathing pattern without the need of respiratory paus-
es, and hence possibly a more relevant measure of respiratory mechanics during tidal 
breathing.27
The strong inverse relationship observed between R and C (Fig. S3 in the online sup-
porting information) reflects the size effects on the resistive and compliant mechanical 
properties, while the positive correlation between R and I indicates the large contribution 
of the upper airways to the respiratory impedance.  
Male infants in the present study had a higher R and lower C as a group, compared to the 
female infants. This is consistent with previous studies that have shown male infants to 
have reduced early life lung function as compared to female infants.26 28-32 Hanrahan et al. 
investigated healthy infants at 2 to 6 weeks with SOT and reported that male infants had 
a significantly higher R (0.083 vs. 0.079 cmH2O.s.mL
-1; p=0.003) but a non-significantly 
lower C (5.4 vs. 5.54 mL.cmH2O
-1; p=0.37) compared to female infants.26 Stocks et al. 
tested preterm infants at 5 to 39 days with the SOT and multiple occlusion technique; 
female infants had a non-statistically significant lower resistance than males (95%CI: 
-2.93; p=0.2), and significantly higher time to peak expiratory flow over total expiratory 
time.28 These sex differences in lung function early in life suggest that infant boys may 
have a less mature respiratory system at birth compared to girls. However, it has also 
been suggested in previous reports that postnatal growth and maturation may be fast-
er in boys26 28, which underlines the need for further investigations on the longitudinal 
changes of respiratory mechanics.
Infants of mothers who smoked during pregnancy in the present study had a significantly 
lower C compared to infants whose mothers did not smoke. The relationship between 
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maternal smoking and low infant lung function in early life is well established.33 Forced 
expiratory flow was shown lower in infants whose mothers smoked during pregnancy,32 34 
35; additionally respiratory compliance measured with SOT was reduced in infants at birth 
that had been exposed to in-utero tobacco smoke compared to infants without exposure 
(3.6 vs. 4.8 mL.cmH2O
-1; p<0.001, 95% CI: 0.89 to 1.55).36 The present cohort had a very 
high prevalence of maternal smoke exposure; 43% of infants studied had mothers who 
smoked during pregnancy, and a further 39% of babies had mothers who were exposed 
to environmental tobacco smoke. This is consistent with the low socio-economic status 
of the cohort, where most infants live in overcrowded conditions. 
Thirty-three (19%) infants had HIV-infected mothers; all infants completed the prevention 
of mother-to-child transmission (PMTCT) program and no infants were found to be HIV 
infected. HIV-exposed but uninfected infants have a higher incidence of wheezing illness 
and respiratory infections in early life37 and have an increased risk of pneumonia with 
treatment failure compared to unexposed uninfected infants.38 Whether this is due to in-
creased risk factor exposure, impaired immunity or effect of HIV exposure on early lung 
growth is not known. In this cohort, maternal HIV exposure had no effect on respiratory 
impedance at 6 weeks of age suggesting that low lung function at this early stage may 
not be the reason for increased pneumonia risk in early childhood; however, the data 
need to be interpreted with caution due to the small number of infants included and the 
exclusion of those with previous pneumonia. In addition, this cohort represents a group 
of HIV-infected woman in relatively good health, since they all received antiretroviral 
therapy as part of the prevention of mother to child transmission program. 
Conclusion
The present adaptation of the FOT is sensitive enough to detect the influences of sex 
and maternal tobacco exposure on respiratory mechanics in healthy unsedated infants. 
Further longitudinal studies of the impact of early-life environmental exposures on lung 
development and growth will be important in defining risk factors for respiratory disease.
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Age (weeks) 7.7 (7.0; 8.1) 7.4 (6.7; 8.0) 7.6 (6.9; 8.1)
Weight (kg) 4.9 (4.6; 5.6) 4.7 (4.3; 5.3) 4.8 (4.4; 5.4)*
Weight for age z score -0.2 (-0.7; 0.6) -0.5 (-1.2; 0.3) -0.36 (-0.98; 0.43)*
Length (cm) 56 (53; 57.8) 55 (53; 57) 55 (53; 57)
Length for age z score -0.7 (-1.8; 0.2) -0.7 (-1.8; 0.1) -0.7 (-1.8; 0.1)
Gestational age 
(week)
39 (38; 40) 39 (38; 40) 39 (38; 40)
Birth weight (kg) 3.1 (2.9; 3.5) 3.0 (2.8; 3.5) 3.1 (2.8; 3.5)
Birth weight z score -0.5 (-1.3; 0.04) -0.8 (-1.5; -0.1) -0.7 (-1.4; -0.04)
Birth length (cm) 50 (48; 53) 50.5 (48; 53) 50 (48; 53)
Birth length z score 0.0 (-0.8; 1.0) 0.1 (-1.1; 0.9) -0.0 (-0.9; 0.9)
n (%) n (%) n (%)
Male 38 (48) 51 (52) 89 (50)
Maternal HIV 
(positive)











* statistically significant difference, p<=0.05
Table 2: Respiratory impedance parameters (n=164)




52.8 (19.1) 50.2 (39.5; 60.6) 5.9 (3.6; 9.5)
Compliance  
(mL.cmH2O1)
0.85 (0.42) 0.78 (0.61; 0.99) 13.9 (6.9; 22.1)
Inertance  
(cmH2O.s2.L-1)
0.073 (0.044) 0.062 (0.050; 0.086) 14.0 (7.7; 24.0)
Resonance frequency 
(Hz)
23.7 (6.4) 22.1 (19.5; 26.5) 7.5 (4.1; 11.9)
CoV: intra-subject coefficient of variation
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Figure 1: 
Schematic representation of the forced oscillation equipment. A loudspeaker delivers the 
computer-generated multi-component forcing function. Pressure is measured at each 
end of a wave-tube (P1and P2) for the estimation of respiratory impedance, and a pneu-
motachograph is used to monitor tidal airflow (V’). A bias flow reduces the influence of 
equipment dead-space on the infant’s breathing pattern.
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Figure 2:  
Resistance (R) and compliance (C) by sex, ethnicity, maternal smoke exposure and ma-
ternal HIV. Data are shown as median, 25-75% and 95% confidence intervals. 
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Healthy infants between 6 and 10 weeks of age enrolled in the Drakenstein Child Lung 
Health study (DCHS),16 were eligible for the lung function measures. The DCHS study is 
a multidisciplinary birth cohort investigating the epidemiology and aetiology of childhood 
respiratory illness and the determinants of child respiratory health in a peri-urban area 
in South Africa. The primary aim is to investigate aetiology, progression and risk factors 
for childhood pneumonia and the impact on child health. The DCHS is located in the 
Drakenstein area in the town of Paarl, a peri-urban area, 60 km outside Cape Town, 
South Africa with a population of approximately 200,000. The local economy is based 
around commercial agriculture and light industry. More than 90% of the population ac-
cess health care in the public sector including antenatal and child health services. The 
public health system is comprised of 23 primary health care clinics and one centralized 
hospital, Paarl Hospital, where all births and all hospital based paediatric care, including 
admissions occur. Similar to many low and middle income countries, the area has a high 
burden of childhood diseases and pneumonia 39 and a high prevalence of risk factors 
associated with pneumonia or severe disease, such as tobacco smoke exposure, mal-
nutrition or poverty. Pregnant women were recruited from two primary health care clin-
ics: Mbekweni, of predominantly African ethnicity and Newman predominantly of mixed 
African/other ethnicity. This is a peri-urban, accessible, low socioeconomic community. 
Mother-infant dyads were enrolled at 20-28 weeks’ gestation and will be followed until 
children reach 5 years of age. 
Lung function was tested at 6 weeks of age and is scheduled for 1 year of age and an-
nually until 5 years. The first 219 infants presenting for FOT testing at the 6-week lung 
function visit were included in the current study. Of these, infants born premature (<37 
weeks) and those who had previously had a lower respiratory tract infection were exclud-
ed from the current study. A further 13 infants were excluded for other reasons detailed 
in Fig. S1. The study was approved by the Faculty of Health Sciences, Human Research 
Ethics Committee, The University of Cape Town (401/2009) and by the Western Cape 
Provincial Health Research Committee. Mothers gave informed, written consent in their 
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first language for their infants to participate.
Collection of antenatal and early life data
Maternal smoking was confirmed by a quantitative analysis of maternal urine cotinine 
(IMMULITE 2000 Nicotine Metabolite analyser, Siemens, Los Angeles, USA). Maternal 
urine specimens were collected antenatally and at birth. Smoking exposure based on 
maternal urine cotinine was defined as follows: active smoker, urine cotinine level of 
>500 ng.mL-1; passive smoker, 11- 500 ng.mL-1 and non-smoker <10 ng.mL-1.40 Follow-
ing public sector protocol, all mothers would have had an HIV test at antenatal booking 
visit and repeated at delivery. Testing is done by rapid HIV immunoassay (Determine® 
HIV-1/2, Abbott, Illinois, USA) with a confirmatory ELISA test if the rapid test is positive 
(Enzygnost® Anti-HIV 1/2 Plus, Siemens Healthcare Diagnostic Products, Marberg, Ger-
many). All HIV-exposed children had an HIV PCR test (Cobas Ampliprep system, Roche 
Molecular Systems, New Jersey, USA) done by 6 weeks of age.
Model analysis of impedance
From the measurements of total respiratory impedance (Zrs) the parameters of respira-
tory mechanics were evaluated by fitting a resistance (R) – compliance (C) - inertance (I) 
model to the measured data (Fig. S2). Resonance frequency (fres), the zero crossing of 
the imaginary part of Zrs (Xrs), was calculated as fres=1/(2π√CI). R was obtained as the 
mean value of R between 12 and 32 Hz; the R values at 8 Hz were omitted from the es-
timation of R because of systematically higher values reflecting the contribution of tissue 
resistance in these young infants.1 The R values at >32 Hz were also excluded because 
of occasional elevations in R as a consequence of observed distortion of the parabolic 
airflow profile.41 In order to obtain a balanced contribution from the elastic and inertive 
properties of Xrs to the fitting, C and I were estimated from the Xrs data between 8 and 
32 Hz whenever fres was ≤20 Hz and between 8 and 48 Hz otherwise.
Multivariate analysis of determinants of impedance parameters
The association between the Zrs parameters and anthropometric indices, ethnicity, gen-
der; exposure to active and passive maternal smoking and maternal HIV infection were 
tested in a multivariate linear regression model. Factors showing significant association 
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at a level of p=0.1 on initial univariate analysis (weight, gender and smoke exposure) 
and possible confounders (height, ethnicity, maternal HIV infection) were included in a 
multivariate linear regression model. The data are presented as coefficients, 95% CI and 
corresponding p-values in Table S1. Interactions were examined through stratification by 
gender. No evidence of interaction effects between covariates was found. However the 
study was underpowered for a comprehensive stratification analysis as subgroups were 
very small in sample size, but this was not the primary aim of the analysis.  
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Table S1:  Multivariate analysis of lung function, anthropometry, gender, ethnicity, 
maternal HIV infection and maternal smoking 
RESISTANCE (cmH2O.s.L-1)
 Coefficient 95% CI1 p-value
Weight-for-age z score2 4.23 0.48 7.99 0.027
Length-for-age z score -0.99 -3.76 1.77 0.479
Male 8.62 2.60 14.64 0.005
Ethnicity - African -2.05 -9.14 5.04 0.569
HIV 1.06 -7.37 9.49 0.804
Smoking - Passive -0.47 -9.02 8.07 0.913
Smoking - Active 0.35 -8.96 9.67 0.941
COMPLIANCE (mL cmH2O-1) 
 Coefficient 95% CI p-value
Weight-for-age z score  -0.018 -0.099 0.063 0.667
Length-for-age z score 0.002 -0.058 0.061 0.959
Male -0.161 -0.291 -0.030 0.016
Ethnicity - African -0.070 -0.223 0.083 0.368
HIV -0.090 -0.272 0.093 0.332
Smoking – Passive -0.227 -0.412 -0.042 0.016
Smoking - Active -0.352 -0.553 -0.150 0.001
INERTANCE (cmH2O.s2.L-1)
 Coefficient 95% CI p-value
Weight-for-age  z score  0.007 -0.002 0.015 0.144
Length-for-age z score 0.000 -0.006 0.007 0.971
Male 0.006 -0.008 0.021 0.367
Ethnicity - African -0.010 -0.027 0.006 0.219
HIV 0.002 -0.017 0.022 0.819
Smoking - Passive -0.010 -0.030 0.010 0.306
Smoking - Active -0.010 -0.032 0.012 0.375
RESONANCE FREQUENCY (Hz) 
 Coefficient 95% CI p-value
Weight-for-age z score  -0.831 -2.068 0.406 0.186
Length-for-age z score -0.145 -1.056 0.766 0.753
Male 1.171 -0.811 3.153 0.245
Ethnicity - African 1.414 -0.922 3.750 0.234
HIV 0.042 -2.734 2.818 0.976
Smoking - Passive 2.901 0.086 5.716 0.044
Smoking - Active 5.016 1.948 8.084 0.002
1 95% confidence intervals; 2 weight and height z-scores based on the WHO Child Health Standards 41
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Preterm + pneumonia: n=8
Infant did not sleep: n=3
Equipment problems: n=3





Schematics of the model fitting to the Zrs spectra represented by the real part or resis-
tance (Rrs, top) and imaginary part or reactance (Xrs, bottom). Left: fitting the Xrs data 
in the 8-48-Hz range; right: curtailed frequency range for Xrs data with resonance fre-
quency < 20 Hz.
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Respiratory system resistance (Rrs) at 12 Hz vs. mean resistance (R) from model fitting 
(top); effective compliance calculated from the reactance at 8 Hz vs. compliance (C) from 
model fitting (bottom). Lines of identity are shown.
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Relationships between the compliance (C, top) and inertance (I, bottom) and the resis-
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Chapter 4
Lung function and exhaled nitric oxide in 
healthy unsedated African infants
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Background: Population appropriate lung function reference data are essential to ac-
curately identify respiratory disease and measure response to interventions. There are 
currently no reference data in African infants.
Aim: To describe normal lung function in healthy African infants.
Method: Lung function was performed on healthy infants enrolled in the Drakenstein 
Child Health Study in South Africa. Infants were excluded if they were born preterm or 
had a history of neonatal respiratory distress or prior respiratory tract infection. Mea-
surements, made during natural sleep, included the forced oscillation technique, tidal 
breathing, exhaled nitric oxide and multiple breath washout measures. 
Results: Three hundred and sixty three infants were tested. Acceptable and repeatable 
measurements were obtained in 356 (98%) and 352 (97%) infants for tidal breathing 
analysis and exhaled nitric oxide outcomes, 345 (95%) infants for multiple breath wash-
out and 293/333 (88%) infants for the forced oscillation technique. Age, sex and weight-
for-age z score were significantly associated with lung function measures. 
Conclusion: This study provides reference data for unsedated infant lung function in Afri-
can infants and highlights the importance using population specific data. 
Short title:  Lung function in African infants
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Introduction
Measuring lung function in early life allows assessment of the determinants of early re-
spiratory health and may provide a prognostic and susceptibility measure of respiratory 
disease. This is especially relevant to low and middle income settings (LMICs), where 
there is a very high burden of childhood respiratory disease, however there is very lim-
ited data on infant lung function in these areas. Moreover it is now well established that 
early lung function tracks through to adult hood, predicting diminished lung function and 
chronic respiratory disease in later life. 1 2 
Appropriate lung function data are essential to accurately assess the impact of early life 
factors on lung function and to distinguish between health and disease. Using reference 
data developed from differing equipment or methods or derived from different popu-
lations can lead to misinterpretation of the test results 3. Hence developing reference 
ranges for tests and for a specific population is important. Non-invasive lung function 
measures undertaken in unsedated infants have been developed 4-8 furthering the use 
of infant lung function testing in an epidemiological setting and the development of ro-
bust reference ranges. Reference data for Caucasian infants for both sedated 9-13 and 
unsedated 14 15 lung function tests have been published. Reference data for infant lung 
function outcomes in non-Caucasian subjects 16 are limited and no data are available for 
African infants, nor for infants from LMICs. 
This study aimed to describe the lung function in healthy South African infants living 
in low socio-economic conditions and to provide reference data for tidal breathing pa-





Infant lung function testing was undertaken as part of a birth cohort study, the Draken-
stein Child Health study (DCHS).17 This birth cohort study in a peri-urban, low socio-eco-
nomic community in South Africa, aims to investigate the epidemiology and aetiology of 
childhood respiratory illness and the determinants of child lung health. The lung function 
testing site was established at the local hospital. 
Participants
Healthy infants, enrolled in the DCHS, underwent testing at 5 to 11 weeks.  Infants were 
excluded if they were born preterm (<37 weeks gestation), had a history of respiratory 
distress at birth or prior respiratory tract infection.  Gestation was assessed by antenatal 
ultrasound or by a combination of last menstrual period, antenatal examination of pubic 
symphysis fundal height and birth weight, when ultrasound was not available. 
Antenatal and early life data
Information regarding antenatal, birth and early life exposures and events were collected 
by questionnaire at scheduled antenatal and study visits. 
Lung function measurements
Lung function measurements included tidal breathing (TBFVL), exhaled nitric oxide 
(eNO), sulphur hexafluoride multiple breath washout (MBW) and the forced oscillation 
technique (FOT). Infants were tested from July 2012 to Dec 2013 for TBFVL, eNO and 
MBW and, for operational reasons, from October 2012 to Dec 2013 for FOT. Lung func-
tion measures were taken in unsedated infants during behaviourally assessed quiet 
sleep, as previously published 18 19. A size 0 round infant silicone mask (Laerdal silicone 
mask, Laerdal Medical, Stavanger, Norway) for the TBFVL, eNO and MBW tests and a 
size 0 rigid anaesthetic mask (Neonate crystal anaesthesia mask, no. 39170, Koo Asia, 
Hong Kong) was used for the FOT. All testing conformed to ATS/ERS guidelines. 20-22 
Tidal breathing and exhaled nitric oxide measures were collected simultaneously 
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using the Exhalyser D with ultrasonic flow meter and CLD 88 Exhalyzer chemolumines-
cent analyser (Ecomedics AG, Duernton, Switzerland) as described previously. 6 18 A 90 
second measurement epoch was made during quiet tidal breathing a minimum of 30 sec-
onds after initial mask placement. Recordings were included if >30 consecutive breaths 
(free of sighs, respiratory pauses, irregular volume breaths or air leak) of tidal breathing 
were recorded and analysed according to international guidelines.23 Mean tidal breath-
ing measures, eNO and NO output were calculated using analysis software (Wbreath 
v3.28.0. Ndd Medizintechnik, AG, Zurich, Switzerland).
Multiple breath washouts (MBW) were performed using 4% SF6 as a tracer gas and 
ultrasonic flow meter (Spirison®, Ecomedics, Duernten, Switzerland) with acquisition and 
analysis software (Wbreath v3.28.0, Ndd Medizintechnik AG, Zurich, Switzerland) as 
reported previously. 5 18 24 The washout period began after a ten breath equilibrium period 
was obtained at the end of the tracer gas wash in. The washout continued until the tracer 
gas was eliminated from the lungs. The recordings were defined as acceptable for anal-
ysis if they were free of leak, occurred during quiet sleep; the wash-in equilibrium period 
had a stable tidal volume and a variation of inspiratory and expiratory end tidal inert gas 
concentration of <1%; there were no sighs, breath holds or irregular breathing pattern 
within 10 breaths of the wash-in plateau or 10 breaths after the SF6 concentration had 
returned to baseline, 1/40th the concentration at start of washout.22 Three successful re-
cordings were taken. Test repeatability was defined as functional residual capacity (FRC) 
means within 25% and lung clearance index (LCI) within 1 turnover of each other. The 
mean FRC, LCI and moment ratios of the three tests were reported. If only two success-
ful tests were obtained the tests were reported as the mean of two tests if the FRC mean 
was within 10% of the lower value and the LCI were within 1 turnover of each other. MBW 
indices such as LCI are related to an individual’s underlying respiratory patterns, includ-
ing the respiratory rate, tidal volume and FRC. 25 26 Moment ratios describe the skewness 
of the washout curve and may be less sensitive to the effect of these underlying factors.27 
Mean dilution numbers, M0, M1 and M2 are calculated from the area under the curve of 
the end tidal inert gas concentration and lung turnovers measured.22 The first moment 
ratio was calculated as M1/M0 and the second as M2/M0, using the automated mode 
within the Wbreath software.
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The forced oscillation technique (FOT) measurement was made with purpose built 
equipment. (University of Szeged, Hungary), as previously reported.19 28 A composite me-
dium frequency signal (8-48Hz, peak-to-peak pressure of 2 cm H2O) was delivered to the 
infants via a 10 or 20cm wave-tube through a facemask covering the mouth and nose. 
A minimum of 5 technically acceptable 30-s data epochs was collected. Recordings (or 
short segments of them) that contained breath holds, cries, irregular breathing or leaks 
around the facemask were excluded.  The epochs required at least 10 regular consecu-
tive breaths, free from sighs or breath holds, to be included in analysis. Zrs spectra were 
defined as reproducible if at least 3 of the spectra had Zrs magnitude values within 10% 
of each other. The mean values of respiratory system impedance (Zrs) spectra were 
evaluated by fitting a resistance (R) – compliance (C) - inertance (I) model to the mea-
sured data.28 Resonance frequency (fres) was calculated as fres=1/(2π√CI). 
Ethics
The study was approved by the Faculty of Health Sciences, Human Research Ethics 
Committee, University of Cape Town (401/2009) and by the Western Cape Provincial 
Health Research Committee. Mothers gave informed, written consent in their first lan-
guage for their infants to participate.
Statistical analysis
Descriptive statistics were performed using STATA 13 for windows (STATA Corpora-
tion, College Station, Texas, USA). Data are presented as mean and standard deviation 
(SD) for normally distributed variables and median and 25-75% confidence intervals for 
non-normally distributed variables. Comparisons between populations are presented as 
sample means and standard error. The intra-subject coefficient of variation (CoV) was 
calculated as the ratio of each parameter standard deviation over the parameters mean 
per study participant i.e. for the TBFVL and eNO this is the mean value of included 
breaths and for MBW and FOT the mean of the results from each test. The median and 
IQR of the CoV are reported.
Reference equations were fitted using a stepwise linear regression model with the sig-
nificance level for removal set to significance levels above 0.05. The linear predictions 
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from the reference equations were used to determine the predicted values for each lung 
function measurement. Details of statistical analysis are given in the online supplement. 
Results
Of the 448 infants, 85 infants were excluded (29 had had a prior lower respiratory tract in-
fection and 56 were preterm), giving 363 infants eligible for inclusion, figure 1. The medi-
an age of infants was 7.4 weeks with an equal gender distribution, table 1. Demographic 
and socio-economic factors are shown in table 2. The demographics by enrolment site 
are shown in table E1. Success rates for testing were 356 (98%) of tidal breathing tests, 
352 (97%) eNO and 345 (95%) of MBW tests; and for the FOT, 293/333 (88%). Reasons 
for unsuccessful testing are detailed in figure 1.
Tidal breathing
The tidal breathing group outcomes are listed in table 3.  The CoV ranged from 7.1% 
for minute ventilation to 20% for the ratio of time to peak tidal expiratory flow over total 
expiratory time (tPTEF/tE).  The association with known and possible predictors of tidal 
breathing parameters are shown in tables E2-7 in the online supplement. Weight-for-
age z score was positively associated with tidal volume, minute ventilation and mean 
tidal flows; and negatively associated with respiratory rate. Weight was not a predictor of 
tPTEF/tE. Males had a slightly increased tidal volume (2.3 mL higher compared to females; 
95% CI 1.2 to 3.3, p<0.001) and lower tPTEF/tE  (2.8% lower compared to females; 95% CI 
-5.3 to -0.3, p=0.03).  
Exhaled nitric oxide
Group results for measured eNO and NO output are detailed in table 3.  The median 
intra-subject CoV was small; 4.3% for eNO and 8.0 % for NO output. Associations are 
shown in tables E8 and 9. Age had a small but significant positive association with both 
eNO and NO output. Weight had a weak association with eNO but not with NO output. 
Sex was not associated with NO measures. 
Multiple breath washout
The group results for FRC, the 1st and 2nd moment ratios (M0/M1 and M0/M2) and LCI 
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are detailed in table 3.  The median intra-subject CoV was small for MBW measure-
ments, FRC 5.4%, LCI 4.0%, M0/M1 3.8% and M0/M2 8.4%. The results of the multi-
variate analysis for associations of MBW measurements are shown in tables E10-13. 
Age, weight-for-age z score and birth weight z score were associated with FRC in the 
multivariate analysis. No size associations were found for the moment ratios or LCI. No 
predictive equation was appropriate for the moment ratios or LCI and the predicted upper 
and lower limits of normal were defined using the observed mean and standard deviation 
as opposed to the predicted. 
Forced oscillation technique
The FOT group outcomes are detailed in table 3. The median intra-subject CoV was 
4.9% for resistance, 11% for compliance and 5.4% for fres. Associations are shown 
in tables E14-16. Length was positively associated with resistance, compliance and 
fres. Weight was positively associated with resistance. Male sex was associated with 
increased resistance, decreased compliance and a slightly higher fres. Stratification by 
sex was considered but did not lead to meaningful differences in reference equations. 
The South African reference equations calculated from these data are listed in table 
E17. The observed data were compared with the values predicted by these reference 
equations and the published European reference equations 15 in table 4. The European 
prediction equations did not satisfactorily predict the South African values. 
Discussion
This large cohort study provides reference data for lung function measures in healthy 
unsedated South African infants early in life, providing reference equations that can be 
used in clinical and epidemiological studies in African children. In addition this study pro-
vides the first reference data for a novel forced oscillation technique in healthy 6-week-
old infants, a safe and feasible measure of respiratory system impedance in unsedated 
infants.
Strengths of this study include the large size of the cohort, the collection of data using 
rigorous methodology by the same trained staff under similar conditions, which adhered 
to ATS/ERS guidelines; the strict quality control during data collection and analysis and 
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the high success rate of testing. Factors contributing towards a high success rate were 
dedicated quiet testing space with a well trained and experienced team skilled in co-ordi-
nating infant sleep and testing; participant families being willing to wait at the testing site 
for infant sleep and the fact that repeat testing was attempted in failed cases. 
A limitation of the study is the narrow age range in which lung function was measured, 
which limits generalizability of these reference data to older children. However this ref-
erence data may be useful in epidemiological studies and in longitudinally assessing the 
impact of early life exposures on lung health. Children from LMICs are at particular risk of 
respiratory disease,29 hence understanding the impact of early exposures on lung growth 
and function in these settings is key.
Comparison with data from high-income settings
There are few data on lung function parameters in healthy unsedated infants using the 
same techniques. Similar tidal breathing, exhaled nitric oxide and multiple breath wash-
out data have been published in European and Australian infants. 15 30 
Tidal breathing
The intra-test intra-individual coefficients of variation (CoV), a measure of test repeat-
ability, of the TBFVL measures were similar to that previously reported using the same 
techniques in 6-week-old infants.8 15 Tidal volume, respiratory rate and flows were similar 
to those previously reported in sedated and unsedated infants, although South African 
infants had a slightly larger tidal volume and minute ventilation compared to European 
infants.15 30 However, South African infants were an average of 2 weeks older and 0.5kg 
heavier than the European infants, accounting for this difference.15 30 
Exhaled nitric oxide
The exhaled nitric oxide was lower in South African compared to European infants, mean 
± SD eNO of   10.1 ± 6.8 in South African vs. 14.3 ± 6.0 European infants.15 
Multiple breath washout
South African infants had a lower FRC and higher LCI (poorer gas mixing efficiency) 
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compared to European and American studies. 15 31 Fuchs et al reported measures using 
the same techniques in European infants of a similar age (mean ± SD 7.2 ± 0.4 weeks 
vs. 6.75 ± 0.6 weeks in European infants). South African infants had a significantly lower 
FRC compared to European infants (mean ± SD FRC 78 ± 17 mL vs. 102 ±16 mL in Eu-
ropean infants). These differences in MBW results may be accounted for in part by differ-
ing hardware and software, but may also represent different populations with particular 
exposures. These data suggest that infants living in low socio-economic conditions with 
high exposure to air pollutants such as tobacco smoke, have early evidence of impaired 
lung growth and function compared to infants from high income areas. 
Forced oscillation technique
No studies have been published of normative data in 6-week-old infants using this ver-
sion of the FOT. However the resistance (R) and compliance (C) CoV are similar to those 
collected using the FOT in newborn infants 28 and older children.32 Direct comparisons 
cannot be made between R and C measured with FOT and other techniques, such as 
the interrupter technique (IT) and single breath occlusion technique (SOT). However R, 
which is relatively frequency independent, is similar to that measured with SOT.11 33 In 
contrast C measured with FOT is lower than that measured with the SOT.11 33 R mea-
sured here was slightly higher than R measured in unsedated European infants using the 
IT.15 Differing measurement techniques may have contributed to the reduced impedance 
in South African infants, but may also be due to population differences. 
Effect of sex on lung function variables
The reduced flow ratio found in males is consistent with previous reports of lower lung 
function in male as compared to female infants.34-37 Male infants had a lower compliance, 
higher resistance and higher resonant frequency. This is similar to previous reports of 
lower compliance in healthy male compared to female infants.11 
The previously published equations in Caucasian European infants did not fit the South 
African data well, despite the data being collected under similar conditions. This high-
lights the importance of reference data being specific not only for the equipment and 
method used, but also for the population studied. 
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Conclusions
This paper is the first description of healthy reference ranges of lung function data in 
African infants. These data provide reference equations for lung function measures in 
unsedated 6-10 week African infants. These data highlight the importance of using refer-
ence data that is specific to the population studied.
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Figure 1: Cohort description before exclusions (N= 448)
Infants with lower respiratory 
tract infection before test 




Specific TBFVL  
exclusions
N=7




Not meeting quality 
criteria: N=2
Specific eNO  
exclusions
N=11




Not meeting quality 
criteria: N=2
Specific MBW  
exclusions
N=18




Not meeting quality 
criteria: N=6
Specific FOT  
exclusions
N =40




Not meeting quality 
criteria: N=12
Included in study:  
FOT
N=333
Acceptable TBFVL tests 
N = 356 (98%)
Acceptable eNO tests N 
= 352 (97%)
Acceptable MBW test 
N = 345 (95%)
Acceptable FOT tests 
N = 293 (88%)
Included in study:  
TBVL/eNO/MBW
N=363
Table 1: Anthropometric characteristics (N = 363)
 Median 25-75% Range
Age  (weeks) 7.4 6.6 – 8.1 5.3 to 11.4
Weight  (kg) 4.8 4.4 – 5.4 2.8 to 6.9
Weight for age z score1 -0.32 -0.97 – 0.44 -4.2 to 2.1
Length (cm) 55 53 - 57 47 to 63
Height for age z score -0.66 -1.7 – 0.2 -5.2 to 2.8
Gestational age (weeks) 39 38 - 40 37 to 43
Birth weight (kg) 3.1 2.8 – 3.5 1.8 to 4.3
Birth weight z score -0.7 -1.4 to -0.1 -3.7 to 1.6
Birth length (cm) 51 48 - 53 35 to 58
Birth length z score 0.003 -0.8 - 0.9 -7.1 to 3.3
1 Z scores calculated using the WHO Child Growth Standards38 and updated Fenton new-born growth charts39
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Table 2: Demographics and socio-economic characteristics of participants 
Total (N=363)
N (%)
Male Sex 181 (50)
Maternal HIV infection 69 (19)
Maternal smoking in pregnancy 121 (34
Caesarean section 69 (19)
Exclusively breastfed 148 (41)
Maternal SES
          Lowest SES 97 (27)
          Low-Moderate SES 85 (23)
          Moderate-high SES 94 (26)
          High SES 87 (24)
Ethnicity
          African 176 (48)
          Mixed ethnicity 187 (51)
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Table 3: Lung function values in healthy South African infants







Tidal Volume mL 34.9 (6.3) 18.86 – 54.24 34.52 (30.78 – 39.0) 7.7 (6.3 – 9.9)
Respiratory Rate 
n.min-1







1598 (1398 – 1810) 7.1 (5.9 – 9.0)
Mean inspiratory 
tidal flow mL.s-1
60.6 (10.6) 34.85 – 102.0 59.2 (53.4 – 66.5) 7.7 (6.2 – 10.3)
Mean expiratory 
tidal flow mL.s-1
50.0 (11.96) 25.00 – 92.93 48.3 (41.0 – 56.9) 9.1 (7.4 – 11.5)
tPTEF/tE % 39.8 (12.1) 12.87 – 82.17 39.9 (31.6 – 46.7) 20.1 (16.8 – 25.2)
Exhaled nitric 
oxide n=352
eNO ppb 10.1 (6.8) 0.20 – 46.20 9.0 (5.0 - 13.7) 4.3 ( 3.4 – 6.5)
NO output 
nL.min-1
33.1 (21.3) 0.3 – 100.0 30.6 (16.5 – 47.5) 8.0 (6.6 – 10.2)
Multiple breath 
washout n=345
FRC mL 77.97 (17) 47.3 – 162.7 75.1 (66.1 – 86.6) 5.4 (3.3 – 7.8)
M0/M1 2.1 (0.1) 1.5 – 2.6 2.1 (2.0 – 2.2) 3.8 (2.2 – 5.5)
M0/M2 8.2 (1.1) 3.9 – 11.9 8.1 (7.4 – 8.9) 8.4 (4.9 – 12.4)





-1 48.6 (15.7) 22.0 – 119.7 45.6 (38.1 – 57.2) 4.9 (3.0 – 8.0)
C mL.cmH2O
-1 0.95 (0.44) 0.28 – 3.32 0.87 (0.68 – 1.15) 11.0 (6.1 – 17.9)
fres Hz 22.6 (6.1) 10.7 – 42.0 21.2 (18.7 – 25.4) 5.4 (3.3 – 9.6)
CoV: intra-individual intra-test coefficient of variation, FRC: functional residual capacity, M0/M1: first mean 
dilution number, M0/M2: second mean dilution number, LCI: lung clearance index, tPTEF/tE: ratio of time to 
peak tidal expiratory flow over total expiratory time, eNO: exhaled nitric oxide, R: respiratory system resis-
tance, C: respiratory system compliance, fres: resonant frequency
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Mean (std error) 
Tidal Volume mL 34.90 (0.34) 34.90 (0.21) 33.39 (0.19) *
Respiratory Rate n.min-1 48.11 (0.63) 48.08 (0.20) 45.93 (0.31) *
Minute ventilation mL.min-1 1,627.08 (16.33) 1,624.67 (5.86) #
Mean inspiratory tidal flow 
mL.s-1
60.55 (0.56) 60.50 (0.23) 57.44 (0.36) *
Mean expiratory tidal flow 
mL.s-1
50.05 (0.63) 49.96 (0.17)  #
tPTEF/tE % 39.73 (0.63) 39.71 (0.15)  #
eNO ppb 10.11 (0.36) 10.14 (0.09) 13.13 (0.15) *
NO output nL/sec 8.94 (0.24) 8.92 (0.05) 3.70 (0.03) *
FRC mL 78.01 (0.92) 77.95 (0.34) 107.18 (0.47)*
M0/M1 1.54 (0.01) 1.54 (0.00)  # 
M0/M2 5.92 (0.04) 5.92 (0.01)  # 
R cmH2O.s.L
-1 48.55 (0.92) 48.78 (0.19) §
C  mL.cmH2O
-1 0.95 (0.03) 0.94 (0.01) §
Fres Hz 22.64 (0.36) 22.65 (0.09) §




Statistical analyses were performed using STATA 13 for windows (STATA Corporation, 
College Station, Texas, USA). Weight and length for age z scores were calculated us-
ing the WHO Child Growth Standards “I grow up” STATA package.38 Birth weight and 
birth length z scores were calculated using the Fenton 2013 growth charts for boys and 
girls based on gestational age, birth weight and length.39 Reference equations were fit-
ted using a stepwise linear regression model with the significance level for removal set 
to significance levels above 0.05. The linear predictions from the reference equations 
were used to determine the predicted values for each lung function measurement. Due 
to having a very skewed distribution, exhaled nitric oxide was also analyzed as a log 
transformed variable. However, the significant predictors resulting from the multivariate 
analysis (table E7a) of the transformed variable was not different to the analysis of the 
non-transformed variable (table E7), and hence the non-transformed variable analysis 
was used to develop a prediction equation, as the effect sizes are easier to interpret. 
These were compared to the European reference values 15 by fitting the published refer-
ence equations to the observed data. Significance testing between predicted values was 
done using two sample Student’s t-test with a 0.05 level of significance. 
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Male Sex 81 (46) 100 (54) 181 (50)
Maternal HIV infection 61 (35) 8 (4) 69 (19)
Maternal smoking in pregnancy 26 (15) 95 (52) 121 (34
Caesarean section 37 (21) 32 (17) 69 (19)
Exclusively breastfed 69 (39) 79 (42) 148 (41)
Maternal SES
          Lowest SES 61 (35) 36 (19) 97 (27)
          Low-Moderate SES 48 (27) 37 (20) 85 (23)
          Moderate-high SES 41 (23) 53 (28) 94 (26)
          High SES 26 (15) 61 (33) 87 (24)
Ethnicity
          African 174 (99) 2 (1) 176 (48)




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table E11: Univariate analysis for the first moment ratio (M0/M1)
Univariate Model   
  Coefficient 95% CI p-value
M0/M1
Age at study date (weeks) 0.008 -0.005 0.022 0.227
Male sex 0.022 -0.006 0.050 0.124
Weight-for-age z score 0.006 -0.008 0.019 0.397
Length-for-age z score 0.003 -0.007 0.013 0.510
Birth weight z score 0.008 -0.006 0.023 0.237
Table E12: Univariate analysis for second moment ratio (M0/M2)
Univariate Model   
  Coefficient 95% CI p-value
M0/M2
Age at study date (weeks) 0.068 -0.478 0.183 0.250
Male sex 0.187 -0.049 0.424 0.120
Weight-for-age z score 0.047 -0.068 0.163 0.420
length-for-age z score 0.035 -0.049 0.120 0.408
Birth weight z score 0.074 -0.046 0.196 0.224
Table E13: Univariate analysis for the lung clearance index (LCI)
Univariate Model   
  Coefficient 95% CI p-value
LCI (n FRC turnovers)
Age at study date (weeks) -0.004 -0.049 0.041 0.863
Male sex 0.038 -0.055 0.130 0.423
Weight-for-age z score -0.033 -0.078 0.012 0.150
length-for-age z score -0.011 -0.044 0.022 0.520
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Abstract
Background: Low lung function in early life is associated with later respiratory illness. 
There is limited data on lung function in African infants despite a high prevalence of re-
spiratory disease. 
Aim: To assess the determinants of early lung function in African infants.
Method: Infants enrolled in a birth cohort, the Drakenstein child health study, had lung 
function measured at 6-10 weeks of age. Measurements, made with the infant breath-
ing via a facemask during natural sleep, included tidal breathing, sulphur hexafluoride 
multiple breath washout and the forced oscillation technique. Information on antenatal 
exposures was collected using questionnaires and urine cotinine. Household benzene 
was measured antenatally.
Results:  Successful tests were obtained in 645/675 (95%) infants, median (IQR) age 
of 51 (46-58) days. Infants whose mothers smoked had lower tidal volumes [-1·6mL 
(95%CI -3·0 to -0.1), p=0.04] and higher lung clearance index [0.1 turnovers (95%CI 
0·01 to 0·3), p=0.03] compared to unexposed infants. Infants exposure to  alcohol in ute-
ro or household benzene had lower time to peak tidal expiratory flow over total expiratory 
time ratios, 10% (95%CI -15·4 to -3·7), p=0·002) and  3·0% (95%CI -5·2 to -0.7, p=0·01) 
lower respectively compared to unexposed infants.
Conclusions: We identified several factors including maternal smoking, maternal alco-
hol and household benzene associated with altered early lung function, factors amenable 
to public health interventions. Long-term study of lung function and respiratory disease in 
these infants is a priority to develop new strategies to strengthen child health. 
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Introduction
Pneumonia is the leading cause of death in children in low and middle income countries 
(LMIC)1 and chronic respiratory illness is a common sequela.2 There is increasing evi-
dence that chronic respiratory disease in later life has its origins in childhood, with low 
lung function in early life being associated with lung function impairment and chronic 
respiratory illness in later life.3 Identifying pre and postnatal factors associated with early 
lung disease, as measured by lung function, will provide a better understanding of how 
early life exposures influence childhood lung disease and possibly provide insights into 
prevention of subsequent chronic respiratory illness. The normal development of the hu-
man lung begins in utero but continues in post-natal life until adolescence. Thus in utero 
and early life factors that damage or impair lung growth may have a considerable impact 
on early lung function. 
Several risk factors for altered early lung function or respiratory disease in childhood 
have been identified including infant birth weight4, prematurity5, early life respiratory tract 
infections6, maternal asthma7, HIV infection8, maternal alcohol use9 and environmental 
factors such as tobacco smoke exposure10 and household air pollution11. Many of these 
factors are common in Africa but there are no data on early lung function in these settings 
despite the high burden of childhood respiratory disease. 
We aimed to investigate the impact of antenatal and early life exposures on lung function 




Infants enrolled in a birth cohort study, the Drakenstein Child Health study (DCHS)12, had 
lung function tested. This study, set in a peri-urban, low socio-economic community in 
South Africa, aims to investigate the epidemiology and aetiology of childhood respiratory 
illness and the determinants of child health.  Participants were enrolled at two primary 
care clinics, Mbekweni, serving a predominantly black African population and Newman, 
serving a predominantly mixed race population. Lung function testing was undertaken at 
the local hospital. 
Participants
Infants underwent testing at 5 to 11 weeks of age corrected for prematurity (37 weeks). 
Infants born <32 weeks gestation or with congenital anomalies, were excluded from 
this analysis. Mothers had spirometric lung function (Jaeger Masterscope, CareFusion, 
Switzerland) at the same visit, provided they had not had a respiratory infection within 
the last 2 weeks.
Exposures
Information regarding antenatal, birth and early life exposures and events were collected 
by questionnaire at scheduled antenatal and study visits. 
Maternal chronic respiratory illness was defined as at least one of: doctor diagnosed 
asthma, chronic cough or recurrent wheeze in previous 12 months and/or low forced 
expiratory volume in 1 sec (FEV1), defined as FEV1 < -1.64SD predicted using the 
Global Lung Initiative multi-ethnic equations.13 Maternal stress and alcohol intake during 
pregnancy were assessed using the SRQ-20 and Alcohol, Smoking and Substance In-
volvement Screening Test (ASSIST) self-reported questionnaires completed at 28 – 32 
weeks gestation.14 The SRQ-20 is a widely used WHO-endorsed measure of psycholog-
ical distress.15 We used a dichotomous score of “high risk” versus “low risk”, with “high 
risk” defined as a score of ≥8.15 Infants were classified as alcohol-exposed in utero if their 
mother reported daily and/or weekly use of alcohol during three months of pregnancy.  
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Maternal smoking history was corroborated on a quantitative analysis of maternal urine 
cotinine (IMMULITER 1000 Nicotine Metabolite Kit, Siemens Medical Solutions Diag-
nostics, Glyn Rhonwy, UK) collected antenatally and at birth. Smoking exposure based 
on urine cotinine was defined as: active smoker if urine cotinine >500 ng.ml-1, passive 
smoker if urine cotinine 10-500 ng.ml-1 and non-smoker if urine cotinine <10 ng.ml-1.16 
Benzene, a household air pollutant, was measured at an antenatal home visit using 
a MarkesR thermal desorption tube left in the home for two weeks. The South African 
National Ambient Air Quality standards of 5mcg/m3 was used to define above and below 
threshold values for benzene.17
Infant Lung function measurements
Lung function measurements included tidal breathing (TBFVL), sulphur hexafluoride 
(SF6) multiple breath washout (MBW) and the forced oscillation technique (FOT). In-
fants were tested from July 2012 to Dec 2014 for TBFVL and MBW and, for operational 
reasons, from October 2012 to Dec 2014 for FOT. Lung function was measured in unse-
dated infants during quiet sleep and conformed to ATS/ERS guidelines18 19, as previously 
published.20 21 
Tidal breathing measures of tidal volume (VT), respiratory rate and expiratory flow ratios, 
were collected using the Exhalyser D with ultrasonic flow meter (Ecomedics AG, Duern-
ton, Switzerland) and analyzed using analysis software (Wbreath v3.28.0. Ndd Mediz-
intechnik, AG, Zurich, Switzerland), as described previously.20 Multiple breath washouts 
(MBW) measuring the functional residual capacity (FRC) and lung clearance index (LCI) 
were performed using 4% SF6 as a tracer gas and ultrasonic flow meter (Spirison®, Eco-
medics, Duernten, Switzerland) with acquisition and analysis software (Wbreath v3.28.0, 
Ndd Medizintechnik AG, Zurich, Switzerland) as reported previously. 22 Measurements 
of respiratory system resistance (RRS) and compliance (CRS) with the FOT were made 
with purpose built equipment (University of Szeged, Hungary) using a medium frequency 
signal, as previously reported.23 24 
Ethics
The study was approved by the Faculty of Health Sciences, Human Research Ethics 
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Committee, University of Cape Town (401/2009) and by the Western Cape Provincial 
Health Research Committee. Mothers gave informed, written consent in their first lan-
guage for their infants to participate.
Statistical analysis
Descriptive statistics were performed using STATA 13 for windows (STATA Corporation, 
College Station, Texas, USA). Data are presented as mean and standard deviation (SD) 
for normally distributed variables and median and interquartile range (IQR) for non-nor-
mally distributed variables.  Potential determinants of early lung function were identified 
using a causal diagram. The association of these factors and specific lung function out-
comes were investigated using a multiple linear regression model. Co-variates were 
included in the model if statistically significant at a p<0·05 or had a biologically plausible 
bearing on lung function outcomes. Stratification by both enrolment site and sex were 
assessed, neither were statistically different. 
Results
Between July 2012 and Dec 2014, 690 infants were tested, of whom 15 were excluded 
as they were very-preterm [13 (2%)] or had congenital abnormalities [2 (0·3%)], figure 1. 
Infant testing was done at a median (IQR) of 51 (46-58) days, anthropometry of enrolled 
infants are shown in table 1. 
Black African infants were of lower socioeconmic status (SES), less likely to have been 
breastfed and had higher HIV exposure compared to mixed race infants, who had higher 
rates of tobacco smoke exposure, table 2.  Despite an HIV prevelance of 18%, no infants 
were HIV-infected due to a strong prevention of mother to child transmission program 
that included antiretroviral therapy to all HIV-infected pregnant women and to infants for 
6 weeks post partum.
Successful measurements were obtained in 649 (95%) of tidal breathing, 614 (90%) 
MBW and 508/645 (79%) FOT measures, table 3.
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Associations of early lung function
The results of the univariate and multivariate analyses of associations with lung function 
measures are shown in table S1-9.
Infant growth and lung maturation
Infant size and age, weight-for-age z score (WAZ), was associated with larger VT, with 
VT increasing by 2.5mL for every unit increase in WAZ (p<0·001; 95% CI 1·9-3·1). Birth-
weight z score, was associated with lower respiratory rate [difference -3 bpm (95%CI -4 
to -1), p<0·001], larger FRC (4mL (1·8 to 6·1), p<0·001] and higher Crs, [0·06 mL.cmH20
-1 
(0·01 to 0·12),p=0·03]. Gestational age was associated with a small but statistically sig-
nificant decrease in respiratory rate [-1bpm per week increase; (-1·4 to -0·1)p=0·02], 
increased VT [0·4mL (0·1 to 0·7)p=0·006,], larger FRC [2·6mL 90·3 to 2·2) p=0·01] and 
increased Crs [0·03 mL.cmH20 (0·006 to 0·06), p=0·02] at 6-10 weeks of age. However 
neither somatic growth at birth nor at testing, nor gestational age, were associated with 
the tidal expiratory flow ratio: time to peak tidal expiratory flow over total expiratory time 
(tPTEF/tE) and Rrs.
Sex and ethnicity
Male infants had larger VT compared to female infants [2·4mL difference (95%CI 1·4 
to 3·4), p<0·001] but lower tPTEF/tE [-3·3% ( -5·5 to -1·0), p=0·004], higher Rrs [4·1 cm-
H2O.s.L
-1 (1·0 to 7·3), p=0.01] and lower Crs [-0·12 mL.cmH20 (-0·2 to -0·03), p=0·008].
Black African infants had a higher respiratory rate [3·4 bpm difference (95%CI 10·8 to 
6·0), p=0·01], increased tPTEF/tE  [4·4% (1·7 to 7·2), p=0·002]  and increased inspiratory 
time over total breath time (tI/ttot) [1·3% (0·2 to 2·4), p=0·02], but similar VT compared to 
infants of mixed ethnicity. Ethnicity had no effect on other lung function outcomes mea-
sured.
Socioeconmic and environmental factors
Infants’ whose mothers smoked during pregnancy had lower VT [-1·6mL (95%CI -3·0 
to -0·1), p=0·04] and higher LCI [0.1 FRC turnovers (0·01 to 0·3), p=0·03] compared to 
infants whose mothers did not smoke during pregancy. The tPTEF/tE , FRC  and Crs were 
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also lower in smoke exposed compared to non-exposed infants, but these did not remain 
statistically signficant after correcting for predictors and confounders. Infants living in 
homes with high levels of household benzene had lower tPTEF/tE  [-3·0 % (-5·2 to -0·7), 
p=0·01] compared to infants from low level households. Household benzene exposure 
had no effect on other lung function outcomes. Socioeconmic status was not associated 
with lung function differences.
Maternal factors
High maternal distress scores, breastfeeding practises and history of maternal chronic 
respiratory illness were not associated with lung function outcomes. Infants of HIV-infect-
ed mothers had higher VT [1.7 mL (95%CI 0·06 to 3·3), p=0·04] compared to infants who 
were not HIV-exposed, but no other differences in  lung function were observed.
Infants whose mothers drank alcohol during pregnancy had lower respiratory rates [-7 
bpm (-13 to -2), p=0.009 ] higher tider volumes [3·0 mL (CI 0·4 to 5·5), p=0·2] and lower 
tPTEF/tE  [-10% (-15·4 to -3·7), p=0·002 ] compared to infants whose mothers did not drink 
alcohol.
Previous pneumonia
Thirty-five (5%) infants had a lower respiratory tract infection prior to lung function testing 
(table 2). These infants had similar lung function at 6 weeks to infants who had not had 
pneumonia after adjusting for confounding factors (tables S1-S9). 
Dicussion
This is the first study from a low middle income country setting to show several antena-
tal and early life factors that impact on lung function, affecting both lung structure and 
control of breathing in 6 week old African infants.  Known factors such as infant growth, 
sex and maternal smoking were identified as well as novel risk factors such as maternal 
alcohol ingestion and HIV-exposure. 
Different antenatal and early life exposures affected either lung structural development 
as evidenced by reduced lung volumes, ventilation homogeneity and lung compliance; 
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or control of breathing with effects on respiratory rate and flow ratios or both. Somatic 
growth, age and gestational age primarily affected lung development, while ethnicity, al-
cohol exposure, HIV exposure or benzene affected control of breathing; sex and tobacco 
smoke exposure affected both.
As expected infant size both at testing and at birth was associated with increased lung 
size and respiratory system compliance (Crs) at 6 weeks. Size at birth is associated with 
early lung developement.25 The fact that resistance was not associated with somatic 
growth in this study is likely related to the measurement method which, by using a mask 
over the mouth and nose, includes the resistance of the upper airway which is large and 
dominates the measured effect on the respiratory system resistance.26
Our findings of sex differences in lung function are consistent with previous reports of low 
lung function in male infants27 28, suggesting that male infants may have a less mature 
respiratory system at birth with smaller airways and FRC compared to female infants. 
Lower early lung function in boys may be one factor contributing to the higher rate of 
pneumonia in  boys.29
The effect of ethnic differences may be difficult to distinguish from sociocultural and en-
vironmental factors. However even after adjusting for exposure differences, lung function 
remained different between Black African and mixed race infants. Black African infants 
had higher respiratory rate and longer flow ratios, but similar lung volumes and imped-
ance to mixed race infants, suggesting a different early pattern of breathing in African 
infants. This is consistent with previously described ethnic differences between Black 
Afro-Caribbean and Caucasian European infants .27 30 
Smoke exposed infants had smaller lung volumes and reduced ventilation efficiency 
suggesting early structural lung impairment. Previous studies have shown that both in 
utero smoke exposure 30  and early life environmental exposure to tobacco smoke (ETS) 
impair early lung function.10 In this study we were unable to distinguish between the effect 
on lung function of in utero or early life smoke exposure as lung function was measured 
a few weeks after birth. As our cohort had an extremely high passive smoke exposure 
rate (75%), it is likely that some of the effects seen are due to ETS in early life. Although 
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altered control of breathing has been described in smoke exposed infants,31 our lung 
function measures may not be sensitive nor specific enough to detect these effects.
Infants exposed to high household benzene levels had lower tPTEF/tE  which may be relat-
ed to airway obstruction or to breathing pattern. The tI/tTOT more specifically reflects the 
central control of breathing, but was not associated with benzene exposure in this study. 
Further research evaluating the impact of antenatal and early exposure to indoor air pol-
lutants on lung health is needed. 
Socioeconmic status did not impact lung function outcomes. This may reflect the overall 
pooor socio-economic status of the populations studied. Prior pneumonia also did not 
affect lung function, however the number of children with pneumonia was very small, and 
the study was therefore not adequately powered to investigate this.
Consistent with several other studies, we found no association between maternal chron-
ic respiratory illness and infant lung function. 32-34  
This is the first study to show an effect of alcohol exposure on infant lung function. The 
deleterious effect of alcohol exposure on the developing fetal brain is well understood 
and described,  providing a possible basis for altered control of breathing in alcohol 
exposed infants. In addition in utero alcohol exposure reduces surfactant protein and 
alveolar macrophage function and increases lung susceptibility to trauma and infection in 
animal models.35 36 Animal studies have also shown alcohol exposure during pregnancy 
to impact lung growth and structure9, although some do not persist into early postnatal 
life.37 The number of alcohol exposed infants included was small and may have been an 
underestimate of infants exposed due to under-reporting. However, this represents the 
minimum number of alcohol exposed infants, with a very strong association for impaired 
lung function demonstrated. Further research of the potential mechanisms and impact 
is needed. 
This is also the first study to show an association between HIV exposure and lung func-
tion, with exposed infants having higher VT, suggesting an effect on control of breathing. 
This effect may be mediated through HIV or due to ART taken by mothers and infants 
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with dysregulation of metablic pathways.  Further research is needed including long term 
followup of infants, which we are currently undertaking. 
Strengths of this study include the large sample size, the high success rate of testing, 
the reproducibility of lung function testing, the comprehensive lung function testing that 
was done and the measurement of many, diverse potential risk factors that may impact 
on lung function.  In addition, this is the first study to provide lung function measurements 
in African infants.  A limitation is the possible lack of generalisability to other LMICs or to 
other ethnic groups.  However, many of the risk factors described are highly prevalent in 
LMICs.   
We identified several risk factors for impaired lung function that are amenable to public 
health interventions and several that require further study.  Avoidance of maternal smok-
ing and smoking cessation program for pregnant women should be a priority, avoidance 
of alcohol should be stressed and implementing strategies to reduce exposure to ben-
zene should be undertaken in this population.  Long term study of lung function and 
respiratory health in these infants is a priority that we are undertaking to inform new 
strategies to strengthen child health in LMICs. 
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Very preterm infants 13 (2%)
Infants with congenital  
anomalies 2 (0.3%)







Not meeting quality 
criteria: N=6







Not meeting quality 
criteria: N=14







Not meeting quality 
criteria: N=63
Included in study: TBVL/MBW
N=675
Included in study: FOT
N=645
Acceptable TBFVL 
tests n = 645 (95%)
Acceptable MBW test 
n =  614 (90%)
Acceptable FOT tests 
n = 508 (79%)










Med (25; 75) Med (25; 75) Med (25; 75)
Age in days 50 (46; 57) 52 (47; 59) 51 (46; 58) 0·1
Weight kg 4.9 (4.4; 5.5) 4·7 (4·2; 0·3) 4·9 (4·3; 5·4) 0·004
Z score weight -0.2 (-0.8; 0.6) -0·6 (-1·4; 0·1) -0·4 (-1·2; 0·4) 0·0000
Length cm 56 (53; 57) 55 (53; 57) 55 (53; 57) 0·08
Z score length -0·7(-1·7; 0·3) -1·0 (-2·0; 0·0) -0·8 (-1·8; 0·1) 0·003
Birth weight kg 3·1 (2·8; 3·4) 3·0 (2·6; 3·4) 3·0 (2·7; 3·4) 0·02
Z score birth weight -0·4(-1·3; 0·3) -0·8 (-1·5; -0·1) -0·6 (-1·4; 0·1) 0·0003
Gestation weeks 39 (38; 40) 39 (38; 40) 39 (38; 40) 0·7
143










N (%) N (%) N (%)
Sex male 138 (47) 194 (58) 332 (53) 0·01
Maternal smoking
Non-smoker 92 (31) 37 (11) 129 (21) 0·000
Passive exposure 148 (50) 125 (37) 273 (43)
Smoker 42 (14) 162 (48) 204 (32)
Unknown 23 (4)
Household air pollution 
High benzene 135 (46) 131 (39) 266 (42) 0·1
Socio-economic Status
Low 115 (39) 62 (19) 177 (28) 0·000
Low-moderate 77 (26) 76 (23) 153 (24)
Moderate-high 55 (19) 84 (25) 139 (22)
High 47 (16) 112 (33) 159 (25)
Breastfeeding
Exclusive 120 (41) 153 (46) 273 (43) 0·000
Mixed 110 (37) 172 (51) 282 (45)
None 64 (22) 10 (3) 74 (12)
Maternal chronic 
respiratory illness
22 (8) 29 (9) 51 (8) 0·6
Maternal HIV infected 107 (36) 9 (0.3) 116 (18) 0·000
Maternal stress high 60 (20) 71 (21) 131 (21 0·9
Antenatal alcohol 
exposure 
6 (2) 19 (6) 25 (4) 0·07
Previous pneumonia 12 (4) 23 (7) 35 (5) 0·08
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Table 3: Lung function outcomes
Lung function variable Mean (SD) Median IQR
Tidal breathing n=649
Respiratory rate n.min-1 49 (11·5) 47 41; 55
Tidal volume mL 34·7 (6·3) 34·2 30·0; 38·6
tPTEF/tE
*
 % 38·7 (12·2) 38·6 30·2; 46·2
tI/tTOT
*
 % 45·3 (4·8) 45·2 42·0; 48·8
tE/tTOT 
*% 54·7 (4·8) 54·8 51·2; 58·0
Multiple breath washout n=614
Functional residual capacity (FRC) mL 77·0 (15·9) 74·5 65·5; 86·3
Lung clearance index n turnovers 7·2 (0·4) 7·1 6·9; 7·4
Forced oscillation technique n=508
Resistance (Rrs) cmH2O.s.L
-1 47·9 (15·3) 45·0 37·5; 55·8
Compliance (CRS) mL.cmH2O
-1 0·94 (0·4) 0·88 0·67; 1·14
* tPTEF/tE: time to peak tidal expiratory flow over total expiratory time; tI/tTOT: inspiratory time over total breath 
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Lung function in the first year of life in Afri-
can infants: effect of lower respiratory tract 
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158 
Diane Gray MD1, Lidija Turkovic PhD2, Lauren Willemse B.Cur1 , Ane Visagie B.Tech1, 
Aneesa Vanker MD1, Dan J. Stein MD3, Peter D. Sly MD4, Graham L. Hall PhD2#, Heather 
J. Zar MD1#
Affiliations:
1 - Department of Paediatrics and Child Health, Red Cross War Memorial Children’s 
Hospital and MRC Unit on Child and Adolescent Health, University of Cape Town, 
Cape Town, South Africa  2Telethon Kids Institute, University of Western Australia, 
Perth, Australia 3Department of Psychiatry, University of Cape Town, Cape Town, 
South Africa 4Children’s Lung, Environment and Asthma Research, Child Health 
Research Centre, University of Queensland and Queensland Children’s Medical 
Research Institute, Brisbane, Australia  
#These authors contributed equally as senior authors.
Corresponding author:
Dr Diane Gray, Department of Paediatrics and Child Health, Red Cross War Memorial 
Children’s Hospital, Klipfontein Road, Cape Town, South Africa




Lower respiratory tract infections are a major cause of childhood morbidity and mortality. 
It is unknown whether infants are predisposed to respiratory infections due to impaired 
lung function or whether infections reduce lung function.  We aimed to investigate the 
impact of early life exposures, including lower respiratory tract infections on lung function 
during infancy.
Methods
Infants enrolled in an African birth cohort study had lung function at six weeks and one 
year. Testing, during quiet natural sleep, included tidal breathing, exhaled nitric oxide and 
multiple breath washout measures. Risk factors for impaired lung health were collected 
longitudinally. Respiratory tract infection surveillance was performed and episodes in-
vestigated. 
Results 
Lung function was tested in 304 children. Seventy-two (23%) infants had lower respirato-
ry tract infections during the first year of life. Lower respiratory tract infections were inde-
pendently associated with decreased tidal volume (-3.6 mL, 95%CI -6.6 to -0.5; p=0·02) 
and increased respiratory rate (6%, 95%CI 1.01 to 1.10; p=0·01), with stronger effect if 
the infant was hospitalized. Repeat episodes of respiratory infections further increased 
respiratory rate (5%, 95%CI 1.02 to 1.08; p=0.001), decreased tidal volume (-2.5 mL, 
95%CI -4·7 to -0·3; p=0·02) and increased the lung clearance index (0·13 turnovers, 
95%CI 0·00 to 0·26; p=0·05). 
Conclusions
Early life lower respiratory tract infection reduces lung function at one year, independent 
of baseline lung function. Preventing early life lower respiratory tract infections is import-
ant to optimise lung function and promote respiratory health in childhood.
Word count: 249
Keywords: pediatrics, pulmonary function test, epidemiology
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Introduction:
Respiratory disease is a leading cause of childhood mortality and morbidity globally, par-
ticularly in low and middle-income countries (LMIC).1 2 Amongst these, lower respiratory 
tract infections (LRTI) are the leading cause of mortality, with the peak incidence in the 
first year of life.1 Despite this the impact of LRTI on lung growth and development has not 
been well studied, especially in LMIC where the burden of LRTI is particularly high. Lung 
development and maturation is incomplete at birth and continues during the first years of 
life making lungs particularly vulnerable to damage during this critical time of lung devel-
opment. Low lung function in early life has been shown to track through childhood and 
into adulthood3 4; further, children born with low lung function have an increased risk of 
respiratory infections and wheezing illnesses in childhood.5-10 LRTI in infancy has been 
associated with reduced lung function in later childhood and adulthood.11-13 However, the 
sparse data from longitudinal studies of lung function in high income settings suggest that 
the effect of respiratory tract infections on later lung function may be mediated through 
reduced lung function prior to the infective episode. 9 10 Understanding the importance 
of LRTI and other risk factors on lung development and subsequent risk of respiratory 
illness, particularly in LMIC where disease burden is concentrated, may inform strategies 
for optimising lung health and preventing respiratory disease.
We aimed to investigate lung function longitudinally from six weeks to one year of age 
and the impact of early life exposures, including LRTI on lung growth during the one year 
in an African birth cohort study, the Drakenstein Child Health Study (DCHS).
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Methods:
Study design and participants
Infants enrolled in the DCHS, were followed from birth until a year of age, during which 
lung function testing was done and close investigation of any LRTI episode was under-
taken. The DCHS is a birth cohort study situated in a peri-urban, low socio-economic 
area outside Cape Town in South Africa.14 Mothers were enrolled antenatally and fol-
lowed through pregnancy at one of two primary care clinics; mother-child pairs were 
followed from birth. Infants attended scheduled study visits at six, ten, fourteen weeks 
and six, nine and twelve months of age, with lung function assessed at six weeks and 
one year. 
Household tobacco smoke exposure or maternal smoking information was collected by 
study questionnaire at each study visit. Maternal alcohol intake during pregnancy was 
assessed using the Alcohol, Smoking and Substance Involvement Screening Test (AS-
SIST) self-reported questionnaires completed at 28 – 32 weeks gestation.15 Infants were 
classified as being alcohol-exposed in utero if their mother reported daily or weekly use 
of alcohol during the past three months. 
A strong LRTI surveillance system was established as part of the DCHS and detailed 
investigation was done at any episode of LRTI. WHO clinical case definitions were used 
to define an episode of LRTI (cough or difficulty breathing and increased respiratory rate 
or lower chest wall in-drawing in a child> two months) or severe LRTI (child < two months 
with increased respiratory rate or lower chest wall in-drawing, or any general danger sign 
in a child of any age).16 In addition each suspected case was examined by study staff 
to confirm the presence of lower respiratory disease. LRTI surveillance was established 
through community health workers, use of cell phones, a dedicated study contact person 
available 24 hours and a network of study staff at community based sites.17 
The study was approved by the Faculty of Health Sciences, Human Research Ethics 
Committee, University of Cape Town (401/2009; 423/2012) and by the Western Cape 
Provincial Health Research Committee. Mothers gave informed, written consent in their 
first language for their infants to participate.
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Lung function measures
Lung function testing was undertaken first at six (5-11) weeks of age corrected for pre-
maturity (<37 weeks) and then at one year (11-13 months). All testing was done in unse-
dated, behaviourally assessed quiet sleep as previously described.18 19 Testing included 
measures of tidal breathing (tidal volume, respiratory rate, inspiratory and expiratory 
flow ratios), exhaled nitric oxide (eNO) a measure of eosinophilic airway inflammation 
and sulphur-hexafluoride (SF6) multiple breath washout (MBW), measuring function-
al residual capacity (FRC) and lung clearance index (LCI), a measure of ventilation 
distribution. Tidal breathing and eNO measures were collected using the Exhalyser D 
with ultrasonic flow meter (Ecomedics AG, Duernton, Switzerland) and analysed using 
analysis software (Wbreath v3.28.0. Ndd Medizintechnik, AG, Zurich, Switzerland) and 
the MBW measures were performed using 4% SF6 as a tracer gas and ultrasonic flow 
meter (Spiroson®, Ecomedics, Duernten, Switzerland) with acquisition and analysis soft-
ware (Wbreath v3.28.0, Ndd Medizintechnik AG, Zurich, Switzerland), as previously de-
scribed.18 19 Low lung function at six weeks was defined as lung function outcome below 
the lower limit of normal using reference equations as published.19 
Statistical analysis 
Lung function outcome measurements were modelled using multiple linear regression to 
assess the impact of different early life exposures on lung function attained at one year. 
Base models were first constructed for each lung function outcome separately using 
Directed Acyclic Graphs (DAGs) for confounder selection. DAGs minimal adjust set of 
variables were selected using a step by step approach described here.20 Early life expo-
sures of interest were then added to the base models one at a time and assessed indi-
vidually. The only exception to this were infants’ lung function measurements at baseline 
(6 weeks) and weight measured at 1 year which were included in most base models be-
cause they explained large percentage of the variability of lung function at 1 year. Height 
and weight were not included in any models simultaneously because of high correlation 
between them (sample correlation = 0.87). 
Interactions were first explored between each early life exposure of interest and lung 
function at 6 weeks as well as weight at 1 year and nine were found. Interactions be-
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tween weight for age, height for age, age at test, sex and lung function at six weeks as 
well as non-linear age terms were also explored based on the previous literature.21-23 
Interactions were retained in the overall model if Wald test p-values were less than 0.1.
Estimated coefficients, 95% confidence intervals and p-values were recorded for each 
early life exposure of interest (Table 3, supplement S2-7). Confounders and interactions 
included in the overall models are summarized in table S1.
Infants were then stratified into quartile by overall model’s predicted lung function at 1 
year, excluding early life exposure of interest. Odds ratios were calculated for each early 
life exposure based on the direction of effect of each lung function outcome: either the 
upper quartile was compared to the lower quartile (for 1 sided effects) or upper and lower 
quartiles were compared to the middle quartile separately (for 2 sided effects). Estimat-
ed odds ratios, 95% confidence intervals and p-values were recorded for each early life 
exposure in the on line supplement.
Statistical analyses were performed using STATA 13 for windows (STATS Corporation, 
College Station, Texas, USA). Weight (WAZ) and height (HAZ) for age z scores were 
calculated using the WHO Child Growth Standards “I grow up” STATA package.24
Results 
Of 1152 infants enrolled at birth in the DCHS between July 2012 and March 2015, 856 
infants had reached six weeks of which 741 (87%) had lung function tested at six weeks; 
496 infants had reached one year of which 398 (80%) were tested at a mean (SD) age 
of 12.0 (0.7) months, figure 1. Paired unsedated six week and one year lung function 
was completed in 304 children, of which 279 (70%) TBFVL, 266 (67%) eNO and 262 
(66%) MBW tests were successful with good quality results. Reasons for exclusions or 
failed tests are shown in figure 1. The anthropometry and results of lung function at six 
weeks and one year, with average within-subject interval change is shown in table 1. 
Between the six week and one year test the Respiratory rate decreased by an average 
of 17 b.p.m, tidal volume (VT) increased by an average of 56.1 mL, a 2.6 fold increase 
and the FRC by 120 mL, a 2.5 fold increase. The tPTEF/tE decreased 8% and the average 
lung clearance index reduced by 0.4 turnovers.
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The cohort demographics and exposures are shown in table 2. Two hundred and one 
(66%) infants were exposed to household tobacco, with 98 (32%) infants having a moth-
er who smoked. Twelve (4%) infants had mothers who drank during pregnancy. Six-
ty-one (21%) mothers were HIV-infected, however due to the well-functioning prevention 
of mother to child transmission programme no infants were HIV infected. There were 
72 (24%) infants who had at least one episode of LRTI in the first year, of which 38/72 
(53%) had associated wheeze. Fifteen (5%) infants had more than one episode. Nine 
infants (3%) had severe LRTI, 24 (8%) infants were hospitalized and 9 (3%) received 
supplemental oxygen.
Lung function between six weeks and one year
Figure 2 illustrates the tracking of lung function from six weeks to one year. Infants with 
low lung function at six weeks had 8% higher respiratory rate (95%CI 1.04 to 1.12; 
p<001), 8.6 mL lower VT (95%CI -12.3 to -5.0; p<0.001), 4% lower tPTEF/tE and 13mL low-
er FRC (95%CI -25.6 to -0.1; p=0.05) at one year compared to infants who did not have 
low baseline function. 
Determinants of lung function at one year
The results of the linear regression model of associations with lung function at one year 
are summarised in table 3 and full analyses are shown in table S2 to 7. After controlling 
for low baseline lung function, growth and other confounding factors (table S1), infants 
who had a LRTI episode had reduced lung function at one year compared to infants who 
did not have a LRTI during the first year of life, with an average 6% higher respiratory 
rate (95% CI 1.01 to 1.10; p=0.01) and 3.6 mL lower VT (95%CI -6.6 to -0.54; p=0.02). 
Timing of a LRTI was not associated with lung function at one year, but infants with more 
than one episode of LRTI had a higher LCI compared to infants who did not have a LRTI 
(0.13 turnover higher, 95%CI 0·00 to 0·26; p=0·05). The effect on one year lung function 
was greater if the LRTI required hospitalization with a 10% increase in respiratory rate 
(95%CI 1·03 to 1·17; p=0·007) and 6 mL decrease in VT (95%CI -11·2 to -0·7; p=0·03). 
Low baseline lung function was not associated with risk of LRTI during the first year of 
life, but low baseline lung function and LRTI had an additive effect on lung function out-
come at one year. Exhaled nitric oxide was not associated with LRTI or any lung function 
165
outcome at one year, table S7 and S13.
Infant growth was a strong predictor of lung function at one year. For every WAZ increase 
infants had a 4.2 mL higher VT (95%CI 3.0 to 5.3; p<0.001), 13.3 mL higher FRC (95%CI 
6.8 to 19.8; p<0.001) and 0.13 turnover lower LCI (95%CI -0.21 to -0.06; p<0.001). Age 
related weight gain measured as change in WAZ between six week and one year testing, 
though associated with increased VT and FRC, was associated with a 4% lower tPTEF/tE for 
every WAZ increase (95%CI 0.92 to 1.0; p=0.03). 
Exposure to household tobacco smoke during the first year of life was associated with a 
higher LCI [0.2 turnovers (95%CI 0.00 to 0.39), p=0.046] compared to infants who were 
unexposed. Infant’s whose mothers were HIV-infected had a 6% increase in respiratory 
rate (95%CI 1.01 to 1.11; p=0.028) at one year compared to infants whose mothers were 
uninfected. 
Neither being born premature nor maternal alcohol intake during pregnancy where sig-
nificantly associated with lung function change during the first year after adjusting for 
confounding factors.
Independent predictors of low lung function at one year 
The results of the regression analysis of infant growth and early life exposures on the 
risk of having low lung function at one year are expressed as odds ratios (OR), 95% CI 
and p values summarised in table 3, with comprehensive output shown in table S8 -13 
in the online supplement. 
LRTI in the first year of life more than doubled a child’s risk of having a respiratory rate in 
the highest quartile at one year [OR 2·2 (95%CI 1·1 to 4·0), p=0·01] and every additional 
LRTI increased a child’s risk of having an increased respiratory rate at 1 year by 50% 
[OR 1·5 (CI 1·0 to 2·3) p=0·05]. 
Improved nutrition during the first year of life as measured by a change in WAZ between 
six weeks and one year predicted better lung function at one year. Every unit increase 
in WAZ reduced the chance of having a low VT at one year by 91% [OR 0.09 (CI 0.04 to 
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0.2), p<0.001], low FRC by 53% [OR 0.47 (95%CI 0.3 to 0.7), p<0.001] and a high LCI by 
92% [OR 0.08 (CI 0.04 to 0.2), p<0.001]. Similarly an increase in HAZ reduced the risk 
of having low VT by 34% [OR 0.66 (CI 0.5 to 0.9, p=0.003) and a high LCI by 50% [OR 
0.5 (CI 0.4 to 0.7), p<0.001]. 
Late preterm infants (33-37 weeks gestation) had nearly three times the risk [OR 2.6 
(95%CI 1.2 to 5.7), p=0.002] of having a low VT at one year compared to infants born at 
term. There were too few very preterm infants (<33 weeks gestation) in each quartile to 
assess risk.  Infants of HIV-infected mothers were 58% less likely to have low VT [OR 
0.42 (95%CI 0.18 to 0.98) p=0·3] and 70% less likely to have low FRC [OR 0.3 (0.11 to 
0·83) p=0.02] at one year compared to infants whose mothers were uninfected. They 
were also three times more likely to have a tPTEF/tE in the highest quartile at one year [OR 
3.0 (95%CI 1.3 to 7.0), p=0.01]. Infants whose mother drank alcohol during pregnancy 
were five times more like to have a reduced FRC [OR 4.9 (95%CI 1.2 to 20.2) p=0.03]. 
Being exposed to household tobacco smoke doubled an infant’s risk of being in the low-
est quartile VT at one year [OR 1.9 (95%CI 1.0 to 3.8), p=0.06]. This effect was similar 
if the infant’s mother was the household smoker [OR 1.88 (95%CI 1.0 to 3.8), p=0.065]. 
Discussion
This is the first study in a LMIC to describe changes in lung function and the impact of 
early life LRTI on child lung health. Lung function during this critical period of lung devel-
opment tracked from early life, with low lung function soon after birth a strong predictor 
of lung function at one year. LRTI were identified as a key factor associated with reduced 
lung function at one year, with more severe disease and recurrent infections associated 
with a further reduction in lung function. Other factors identified that impacted normal 
lung growth included infant nutrition, prematurity, exposure to household tobacco and 
maternal HIV infection. 
Previous reports of LRTI in early life and later lung function suggested that the effect of 
LRTI on lung function was mediated by pre-existing low lung function.10 25 In the current 
study low lung function at six weeks was not associated with increased risk of LRTI 
during the first year. The independent effect of LRTI and infection severity on lung func-
167
tion outcomes at one year is an important finding in view of the fact that lung function is 
known to track to later life and increase risk of later respiratory disease.3 4 Longitudinal 
follow-up of these infants is currently underway.
The tracking of lung function during the first year of life is in keeping with described pat-
terns of early lung development. 26 27 The increase in VT and FRC during the first year re-
flects the rapid and non-linear association of lung and somatic growth28 and the decrease 
of tPTEF/tE , the dysanaptic growth of lung parenchyma and airways during this period of 
development.29 
Although postnatal growth is associated with increased lung volumes, large postnatal 
weight gain is associated with reduced expiratory flows.30 31 We found decreased ex-
piratory flow ratios (tPTEF/tE) in infants who had increased WAZ between six weeks and 
one year despite this being associated with increased lung volumes. Hence optimising 
nutrition is important in promoting respiratory health in infancy.
We have already described the negative impact of maternal smoking during pregnancy 
on lung function at 6 weeks in this cohort.32 33 Subsequent household exposure to tobac-
co smoke had an effect, independent of baseline lung function, of increased LCI and a 
trend to a higher FRC. This may reflect airway inflammation and/or damage rather than 
impaired growth. The fact that maternal smoking did not have a stronger effect than 
household smoke exposure reflects the very high exposure to environmental smoke and 
overcrowded living conditions in this setting.
Although prematurity was not independently associated with lung function outcomes at 
one year, being born premature was a strong predictor of having VT in the lowest quartile, 
suggesting that decreased lung volumes in preterm infants are mediated by reduced so-
matic size.34 Most children in this cohort were born full term and those that were preterm 
were late preterm infants, hence the impact of prematurity on lung function is unlikely to 
be substantial in this cohort.
Infants whose mothers were HIV-infected had higher respiratory rates compared to 
those with uninfected mothers, equating to a significantly raised minute ventilation in HIV 
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exposed compared to HIV unexposed infants [2·8 L.min-1 vs. 2·6 L.min-1 (95%CI 2·6 to 
2·7); p<0·001]. This may be related to a sustained effect of exposure to the HIV virus in 
utero, exposure to antiretroviral therapy as part of prevention of disease transmission 
or differing nutritional management in early life. The effect of maternal HIV and early life 
antiretroviral therapy on respiratory control in early life needs further study.
Strengths of this study are the large sample size of matched lung function collected by 
the same investigators, using the same testing techniques. Lung function was undertak-
en in a community-based cohort with robust LRTI surveillance and simultaneous mea-
surement of comprehensive risk factors for impaired lung growth. Our symptom-based 
definition of LRTI allowed us to assess the impact on lung function at a population level 
of community acquired respiratory tract infections.  This definition aligns with relevant 
epidemiological studies investigating LRTI in high burden settings.35 A further strength is 
measurement of lung function prior to an infective episode, enabling accurate assess-
ment of pre-respiratory tract infection lung health. Limitations of the study are the poten-
tial lack of generalizability to other settings with different exposures.
In summary, this study describes the tracking of lung function in the first year of life in a 
cohort of infants living in a high respiratory disease burden setting.  It identifies LRTI as 
an independent risk factor for reduced lung function at one year, highlighting the impor-
tance of development of strategies to prevent LRTI in early life. Other risk factors include 
infant nutrition, maternal HIV infection and smoke exposure, factors amenable to public 
health interventions. Given that infant lung function tracks into later life and plays a role 
in chronic respiratory disease, preventing respiratory illness in young children, reducing 
exposure to environmental tobacco smoke and optimising nutrition are further key prior-
ities to strengthen child respiratory health.
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Figure 1. Cohort description before exclusions (N=1152)
Acceptable TBFVL test at 1 year
  279 (70%)
Acceptable eNO test at 1 year
  266 (67%)




26 insufficient quiet sleep
8 technical problems
8 did not meet quality criteria
Specific eNO exclusions
38




21 insufficient quiet sleep
4 technical problems
94 infants failed to achieve sleep and were not tested.
Infants tested at 1 year: TBVL, eNO and MBW
398 (80%)
Infants eligible for 1 year 
testing
496
Infants tested at 6 weeks 
741(87%)
Infants eligible for 6 week 
testing  
856




30 participants could not be 
contacted or did not attend 
appointment
17 infants away during testing 
period
51 parents had withdrawn from 
study
Reason not tested:
53 participants could not be 
contacted or did not attend 
appointment
30 infants away during testing 
period
32 parents had withdrawn from 
study








Figure 2: Lung function outcomes in quartiles at 6 weeks and 1 year.


























































































2 4 6 8 10 12
Age (years)
A. Respiratory rate (breaths per minute) B. Tidal volume (mL)
C. Functional residual capacity (mL) D.  Ratio of peak tidal expiratory flow over total 
expiratory time
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Table 1  Infant anthropometry and lung function outcomes at six weeks and one 
year and within-subject interval change





change mean (SE) n=304
Age months 1.72 (0.30) 11.97 (0.70) 10.25 (0.03)
Weight kg 4.88 (0.76) 9.22 (1.40) 4.41 (0.07)
Weight for age Z score -0.39 (1.11) -0.11 (1.31) 0.29 (0.08)
Height cm 55.07 (3.13) 73.33 (3.18) 18.27 (0.21)
Height for age Z score -0.88 (1.45) -0.63 (1.30) 0.25 (0.10)
Tidal breathing measures n=279
Respiratory rate n.min-1 48.81 (11.59) 29.43 (4.92) -17.06 (11.99)
Tidal volume mL 34.65 (6.36) 90.45 (13.30) 56.08 (12.00)
tPTEF/tE % 38.90 (12.40) 30.83 (11.61) -7.98 (13.27)
tI/tTOT % 45.33 (4.71) 43.94 (4.45) -1.56 (5.34)
Exhaled nitric oxide n=266
Exhaled NO 9.8 (6.5) 9.4 (9.2) -0.4 (0.6)
Multiple breath washout measures n=262
Functional residual capacity 
mL
77.39 (16.24) 196.51(45.73) 119.92 (22.50)
Lung clearance index  
n turnovers
7.16 (0.44) 6.73 (0.67) -0.39 (0.84)
tPTEF/tE:  time to peak tidal expiratory flow over total expiratory time, tI/tTOT: inspiratory time over total 
breath time
173
Table 2 Demographics of infants tested at one year of age (n=304)
N (%)
Male sex 157 (51·6)
Black African ethnicity 138 (45·4)
Socio-economic status1
Highest quartile 67 (22·0)
Moderate-high quartile 112 (36·8)
Low-moderate quartile 54 (17·8)
Lowest quartile 71 (23·4)
Preterm
< 37 weeks gestation 45 (14·8)
<32 weeks gestation 6 (2·0)
Small for gestational age 25 (8·2)













Household tobacco smoke exposure (excluding mother) N=303 201 (66·3)
Maternal smoking n=303 98 (32·3)
Maternal alcohol use in pregnancy (n=280) 12 (4·3)
Maternal HIV infection3 61 (20·1)
1Quartiles are internal comparisons within a low socio-economic cohort; 2Severe LRTI was diagnosed in 
children younger than 2 months with tachypnoea (>60 breaths per min) or lower chest wall indrawing, or in 
children of any age if the child had a general danger sign; 3No infants were HIV infected
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Table 3  Associations of lung function and predictors of lowest quartile lung 
function outcomes at one year of age
Overall model  (95% CI) Lowest predicted lung 
function quartile OR (95% CI)
Baseline low lung function
Respiratory rate % change # 1.08 (1.04, 112) 2.12 (1.2, 3.7)
Tidal volume mL -8.64 (-12.29, -4.97) 5.33 (2.12, 13.38)
tPTEF/tE % change # 0.76 (0.55, 0.77) N/A
Functional residual capacity 
mL 
-12.81 (-25.58, -0.05) 0.83 (0.76, 0.91)
Lung clearance index 0.05 (-0.14, 0.25) 0.81 (0.36, 1.82)
Lower respiratory tract infection
Respiratory rate % change 1.06 (1.01, 1.10) 2.17 (1.16, 4.04)
Tidal volume mL (raw score) -3.57 (-6.6, -0.54) 1.22 (0.60, 2.51)
tPTEF/tE % (log transformed) 1.07 (0.98, 1.16) 1.52 (0.76, 2.98)
Functional residual capacity 
mL
-9.05 (-21.29, 3.20) 0.76 (0.37, 1.58)
Lung clearance index 0.13 (-0.06, 0.33) 0.98 (0.47, 2.07)
Infant growth- change in WAZ 
Respiratory rate % change # 1.00 (0.98, 1.02) 1.06 (0.82, 1.36)
Tidal volume mL (raw score) 3.26 (1.97, 4.56) 0.09 (0.04, 0.20)
tPTEF/tE % (log transformed) 0.96 (0.92, 1.00) 1.03 (0.79, 1.35)
Functional residual capacity 
mL
11.67 (6.32, 17.01) 0.47 (0.34, 0.66)
Lung clearance index -0.09 (-0.17, 0.00) 0.08 (0.04, 0.19)
Household smoke
Respiratory rate % change # 1.00 (0.96, 1.04) 0.86 (0.49, 1.49)
Tidal volume mL (raw score) 0.49 (-2.50, 3.48) 1.90 (0.97, 3.75)
tPTEF/tE % (log transformed) 0.99 (0.92, 1.08) 1.44 (0.75, 2.76)
Functional residual capacity 
mL
11.00 (-0.26, 22.27) 1.83 (0.93, 3.63)
Lung clearance index 0.19 (0.00, 0.39) 1.07 (0.53, 2.17)
Prematurity (<37 weeks)
Respiratory rate % change # 0.94 (0.88, 1.00) 2.01 (0.95, 4.27)
Tidal volume mL (raw score) -0.22 (-4.83, 4.38) 2.56 (1.15, 5.73)
tPTEF/tE % (log transformed) 0.98 (0.84, 1.11) 1.18 (0.53, 2.63)
Functional residual capacity 
mL
-12.70 (-32.20, 6.81) 1.21 (0.52, 2.82)
Lung clearance index 0.04 (-0.22, 0.31) 0.88 (0.39, 2.01)
Maternal HIV
Respiratory rate % change # 1.06 (1.01, 1.11) 1.66 (0.88, 3.13)
Tidal volume mL (raw score) 0.70 (-3.41, 4.82) 0.42 (0.18, 0.98)
tPTEF/tE % (log transformed) 1.05 (0.95, 1.15) 0.66 (0.28, 1.55)
Functional residual capacity 
mL
0.29 (-12.10, 12.67) 0.30 (0.11, 0.83)
Lung clearance index 0.18 (-0.06, 0.41) 0.81 (0.36, 1.83)
Maternal alcohol
Respiratory rate % change # 0.99 (0.96, 1.03) 0.64 (0.12, 3.37)
Tidal volume mL (raw score) -1.04 (-8.40, 6.33) 7.55 (0.90, 63.14)
tPTEF/tE % (log transformed) 1.02 (0.81, 1.22) 3.27 (0.89, 2.04)
Functional residual capacity 
mL
-2.68 (-28,71, 23.36) 4.86 (1.17, 20.20)
Lung clearance index 0.07 (-0.38, 0.52) 4.00 (0.43, 36.73)
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This work investigated lung function and growth in African infants in the context of a birth 
cohort study and the antenatal and early life factors impacting this. Comprehensive mea-
sures of lung function were established and performed at six weeks and at one year of 
age. Several important risk factors for altered lung function were identified many of which 
are amenable to public health intervention. 
We obtained the first infant lung function data in African children, showing the feasibility 
of establishing this testing in a LMIC setting and the utility of this.  Importantly, the testing 
success rate was high with success in unsedated six-week infants comparable to that 
published in European cohorts, 1, 2 and with unprecedented success rates in unsedat-
ed one year olds.  Key reasons for this include collaboration with experts, well trained, 
skilled staff, quality control procedures, a dedicated testing space; resources for equip-
ment and staffing and strong community engagement. 
We used a comprehensive set of lung function measures, selecting tests which could 
be done safely during tidal breathing in unsedated infants: tidal breathing measures of 
volume, flow and respiratory rate; exhaled nitric oxide as a measure of airway inflam-
mation and inert gas MBW testing to measure lung growth and ventilation homogeneity. 
These tests were useful in detecting the impact of antenatal and early life exposures on 
lung function both at six weeks and at one year in the context of a birth cohort. We were 
able to successfully test a large number of unsedated infants at one year allowing us to 
measure lung function longitudinally without having to account for the effect of sedation 
on lung function. We also used the FOT, measuring respiratory system resistance and 
compliance. The FOT has only very recently been developed for use during tidal breath-
ing in unsedated infants.3 This research validated the use of this test in unsedated six 
week infants and as a measure sensitive enough to detect the effects of exposures such 
as maternal smoking in pregnancy.4 
The utility of any lung function measure to distinguish between health and disease in a 
population or to detect a significant alteration in measured outcome requires a robust 
normative standard, including knowledge of individual and population level variability. 
Such standards are lacking in lung function outcomes in African infants, children and 
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adults.5 This research has contributed to the development of normative data for healthy 
African infants.6 A limitation of this normative data is the narrow age range in which lung 
function was measured. This limits generalizability of these reference data to older chil-
dren, as lung function is strongly associated with age and growth in early life.7 In addition, 
these data are relevant to children from similar populations with similar exposures, and 
may not be generalizable to other African populations from different socioeconomic set-
tings and with differing environmental exposures. However this reference data may be 
useful in epidemiological studies in similar populations and in longitudinally assessing 
the impact of early life exposures on lung health. Given that children from LMICs are at 
particular risk of respiratory disease,8 robust epidemiological research that improves our 
understanding of the impact of early exposures on lung growth and function in these 
settings is key.
Factors associated with lung function at six weeks
The study identified a number of antenatal and early life exposures that were associated 
with lung function at six weeks of age, some factors that have been previously described 
and some novel. The impact of infant sex, birth weight, ethnicity and maternal smoking 
in this study were consistent with previous reports.9-13 Male infants had lower tidal expi-
ratory flow ratios and respiratory system compliance despite having larger lung volumes 
compared to female infants, suggesting that male infants have relatively smaller airways 
to lung size. These differences between male and female lung function persisted to one 
year, as has been previously described in non-African infants.10 Low birth-weight was 
independently associated with lower respiratory system compliance and smaller FRC in 
early life, highlighting the importance of the in utero environment on, not only somatic, 
but also lung growth. 
Tobacco smoke exposure, which is known to impair lung growth and function in early 
life, was very common in our population with 32% of infants having mothers that smoked 
during pregnancy and 66% of infants exposed to environmental tobacco smoke post-
natally. Infants whose mothers smoked during pregnancy had impaired lung function 
at six weeks, with smaller size adjusted lung volumes, increased lung clearance index 
and reduced respiratory system compliance compared to infants whose mothers did not 
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smoke. This suggests that exposure to antenatal and very early life environmental to-
bacco smoke not only affects lung growth, but may have early damaging effects on small 
airways with reduced ventilation homogeneity. 
There were a number of novel findings in the study such as the impact of indoor air pol-
lutant benzene, maternal alcohol intake during pregnancy and maternal HIV infection on 
lung function at six weeks. These are especially important findings, as these factors are 
highly prevalent in Sub-Saharan Africa. One of the strengths of this study is the inclusion 
of comprehensive measures of the infants’ home environment.14 Benzene, one of the 
indoor pollutants with high levels in this cohort, was associated with reduced expiratory 
flow ratios soon after birth. This supports the sparse infant lung function literature that 
describes altered lung function with exposure to air pollution15 and highlights the im-
portance of the child’s environment in optimizing respiratory health. Maternal health is 
important for healthy pregnancies. 
Maternal factors that were associated with altered lung function in our study were ma-
ternal alcohol use in pregnancy and maternal HIV infection. In utero alcohol exposure 
was found to be a strong independent risk factor for altered lung function at six weeks. 
Although described in animal studies16, 17, altered lung function in early life after in utero 
alcohol exposure has not been previously described in human studies. This interaction 
requires further study. Infants of mothers with HIV infection had higher size adjusted tidal 
volumes at six weeks with higher minute ventilation compared to infants whose mothers 
were HIV uninfected; a difference which persisted to one year. Whether this is related to 
exposure to the HIV virus itself, antiretroviral therapy or differing infant feeding practices 
is not known and requires further research.
Some of the mechanisms behind the association of antenatal and early life exposures 
and impaired early lung function have been identified through epidemiological and phys-
iological studies. For example, intrauterine growth retardation may be caused by im-
paired trans-placental supply of oxygen and nutrients, which leads to longstanding struc-
tural changes of the lungs including decreased surfactant activity and impaired alveolar 
cell maturation.18, 19 Reduction in lung fluid and foetal breathing movements also leads 
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to impaired lung growth. As expected we found an independent effect of low birth weight 
and lung volumes in this cohort. Smoke exposure antenatally and early life may alter 
control of breathing.20 This together with decreased plancental transfer of oxygen across 
the placenta may be responsible for reduced fetal breathing movements, impairing lung 
growth.20 Smoke exposure is also associated with thickened airway walls,21, 22 which 
would contribute to decreased airway complaince found in this cohort. Airway number 
and size may be impaired by early life smoke exposure,23 which could contribute to the 
altered lung volumes and impaired ventilation homogeneity seen in this study. In utero al-
cohol exposure impacts the developing fetal brain, providing a possible basis for altered 
control of breathing in alcohol exposed infants. In addition in utero alcohol exposure 
reduces surfactant protein and alveolar macrophage function and increases lung sus-
ceptibility to trauma and infection in animal models.24, 25 Animal studies have also shown 
alcohol exposure during pregnancy to impact lung growth and structure16, although some 
do not persist into early postnatal life.26 These mechanisms may explain the altered re-
spiratory rate and expiratory flow ratio and mildly reduced tidal volumes seen in alcohol 
exposed infants in this cohort, although this effect needs to be confirmed in a larger 
cohort of alcohol exposed infants. Other exposures such as exposure to maternal HIV 
infection require further study to improve our understand of possible underlying mech-
anisms and the relevance of these exposures on longer-term lung function and growth.
Factors associated with lung function at one year
Lung function was found to track from six weeks to one year of age, consistent with 
studies from high-income countries.10 Factors impacting normal lung growth during the 
first year of life included somatic growth, exposure to environmental tobacco smoke, 
maternal HIV infection, maternal alcohol intake during pregnancy and early life lower 
respiratory tract infections (LRTI).
Increased postnatal weight gain was associated with reduced expiratory flows at one 
year, as has been previously described.27 Environmental tobacco smoke exposure during 
the first year of life was associated with reduced lung volumes at one year independent 
of the previously discussed effects on six week lung function. Given that low lung func-
tion in infancy is associated with respiratory illness in later life28, 29, this has public health 
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implications particularly in the context of the rising prevalence of smoking in LMIC such 
as South Africa.30 Maternal alcohol remained an independent predictor of low lung vol-
umes at one year and the increased minute ventilation noted in HIV exposed infants at 
six weeks persisted to one year of age even after adjusting for growth and confounding 
factors.  
Early life LRTI were identified as a key factor in reducing lung function at one year, inde-
pendent of baseline lung function. This is true for even ambulatory non-severe respirato-
ry tract infections. The effect was stronger for more severe LRTI, requiring hospitalisation 
and each additional LRTI led to further reduction in one-year lung function outcomes. 
This is a novel finding as the sparse longitudinal infant lung function data available, sug-
gests that low lung function after early life respiratory infections is mediated by prior low 
lung function. However, these studies were completed in very different populations with a 
lower rate of respiratory tract infections, higher socioeconomic status and likely differing 
epidemiology of respiratory infections. Given the burden of LRTI in African children, this 
finding is particularly important.
Future research should address the following areas:
1. Longitudinal follow-up of this cohort to further investigate the normal lung growth
and development through infancy, preschool and childhood in this African cohort.
This will provide valuable reference data against which the impact of exposures and
potential interventions can be measured.
2. Longitudinal follow-up of this cohort through childhood to investigate the impact of
antenatal and early life factors including LRTI on long-term lung health is important.
3. The pathophysiological mechanisms of exposures and reduced lung function in Af-
rican infants need to be investigated.  For example LRTI may cause direct damage
to lung parenchyma; persistent airway inflammation or possible increased bronchial
hyper-reactivity. Well designed studies to test such hypotheses, systematic develop-
ment of tools able to test the relevant aspects of respiratory function and longitudinal
normative data such as is being collected in this cohort to which effect size can be
related are needed.
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4. Development of lung function tests able to be collected in unsedated preschool chil-
dren and assessment of their clinical utility, including normal variability and defining
bronchodilator response in the African setting. The FOT is a promising technique as
it has the potential to provide information regarding airway obstruction and broncho-
dilator response even in small children who are unable to perform respiratory ma-
noeuvres. This work has laid a strong foundation for development of this technique
as a longitudinal assessment tool of lung function in infants and preschool children
and the potential future development of this technique as a clinical tool in the as-
sessment of respiratory disease in young African children.
We are able to undertake many of these research priorities given the lung function test-
ing capacity that has been developed and the well characterised birth cohort that has 
been established through the Drakenstein Child Health study who we continue to follow. 
Recommendations
This study has identified several areas to optimise lung health in African children by max-
imising early lung growth and function. These include:
5. Optimising maternal health.  Improving maternal health is important to optimise
pregnancy outcomes and maximise child lung health. Maternal HIV infection and
maternal alcohol use are two factors the study has identified as determinants of
normal lung development. Antenatal programmes aimed at reducing alcohol intake
during pregnancy should be considered. Such a programme would need to include
good surveillance and targeted individual and group counselling with assessment
for referral for specialist services.   Strengthening the follow-up of infants exposed
to HIV must be priortised.
6. Reduction in early life respiratory infections The study has identified LRTI in infancy
as an important factor that reduces lung function.  Current available preventative
interventions such as breast-feeding, optimising nutrition, vaccination against com-
mon organisms, prevention of mother to child transmission of HIV infection and re-
ducing exposure to tobacco smoke and environmental pollution should be strength-
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ened.31 In addition, novel interventions to prevent early respiratory infections e.g. 
vaccination of pregnant women against respiratory syncytial virus 32 are priority ar-
eas of research.
7. Reducing tobacco smoke exposure during pregnancy and in early life Our data pro-
vides further evidence for the importance of smoking prevention as a priority public
health intervention. Programmes aimed at smoking cessation in young and pregnant
woman should be prioritized. These must include a combination of group therapy,
supportive therapy and ensure availability of context specific skilled counselling and
appropriate medication.33 The use of vitamin C during pregnancy may ameliorate
the effect of in utero smoke exposure34, but this should not lessen efforts to reduce
smoking in pregnant woman. In addition focussed efforts to reduce smoking in our
communities are needed. This is likely to require broad advocacy from public, pri-
vate and government sectors that includes both smoking prevention and cessation
strategies.
8. Reducing exposure to indoor air pollution This study found that exposure to indoor
air pollution further impacts on infant lung function.  Strategies to reduce indoor air
pollution, such as improved housing with less overcrowding, adequate ventilation
and reliable electricity supply are needed.
Conclusion
Infant lung function was feasible, performed with high success rates and a useful epi-
demiological tool in a South African community setting. Important factors that impact on 
lung health were identified. These included known exposures as well as novel factors 
such as HIV exposure or maternal alcohol use.  These provide targets for strengthening 
respiratory health in African children. The use of this objective measure of lung function 
in African infants has highlighted the importance of population specific data and has laid 
a foundation for ongoing epidemiological research into the respiratory health of African 
infants and a base from which to undertake longitudinal follow-up. 
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Appendix A
Drakenstein Infant Lung Function Study – Consent Form
Thank you for agreeing to be part of the Drakenstein Child Lung Health Study. This form 
contains more detail about the lung function testing part of the study. This is similar infor-
mation to that which you may have read in the lung function information leaflet. Although 
we know you have already signed a consent form at enrolment we want to be sure that 
you have enough information about the lung function testing and that you are happy for 
you and your baby to have a lung function test.
Why is infant lung function being measured?
South African children have a high rate of chest problems such as pneumonia, asthma 
and cough. We know from studies done in other countries that there are many things 
that can be a risk for chest problems in young children such as poor growth, exposure to 
cigarette smoke and other air pollutants and infections. At present we do not know what 
the most important risks are for South African children nor what is normal lung function 
for South African babies as it has not been measured before. By measuring a baby’s 
lung function over time we can find out how big their lungs are, how well the lungs work 
and if they grow normally over time. This study will allow us to find out what is normal 
lung function in South African babies and will provide important information about what 
causes chest disease in children and the effect these things have on lung growth and 
later chronic chest problems. This will help us to understand how best to prevent and 
treat lung disease in our children.
What does infant lung function measure?
The test measures your baby’s lung size and breathing pattern. There are 4 different 
tests but two are done at the same time. 
1. Tidal breathing flow volume test and exhaled nitric oxide test
The first test measures how fast (flow) your baby breaths and how much (volume) they 
breathe with each normal breath. By doing this the equipment can calculate information 
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about the growth and working of your babies lungs. At the same time the equipment can 
measure the amount of a gas called nitric oxide (NO) that is in your baby’s breath when 
they breathe out. NO is a gas that is important in the working of our bodies. We all have 
NO in the air we breathe out. High levels of NO in our breath can mean our airways or 
breathing tubes are inflamed. This has been shown to happen with diseases such as 
asthma, allergies or exposure to pollutants such as cigarette smoke. 
2. Sulphur hexafluoride (SF6) multiple breath washout test
We can also measure the size of your baby’s lungs and the way the different parts of the 
lungs contribute to breathing. We do this by adding a gas (SF6) that does not get ab-
sorbed into the body to the air your baby is breathing. This is breathed for a short period. 
This gas is not smelly or dangerous to your baby. 
3. Forced oscillation technique
This test uses sound waves to test how a baby’s lungs work and can pick up early prob-
lems with a baby’s lung growth and function. 
How are the tests done?
All the tests are done during quiet normal breathing (tidal breathing) when your baby is 
asleep. Your baby will need to be asleep and, while lying on his/her back, a face mask 
with air flowing through it will be placed over your baby’s nose and mouth. This can 
take all the measurements mentioned above. Often babies wriggle, sigh or wake and so 
sometimes we will need to repeat the test. We need to try and get 3 good tests. Depend-
ing on how deeply baby is sleeping it can take anywhere from 20 min to 1 hour and may 
need to be continued after the next feed.
We will repeat these test when your baby is 1year and 2 years old. The tests will be the 
same and will also be done when your child is sleeping. It is less likely that your child 
sleep through the tests the older they get. For this reason we will be try and arrange 
these tests at a time of the day that your child usually sleeps. We will discuss this with 
you when we arrange the appointment. If your child does not manage to sleep through 
the testing and if you are happy for us to do so we will give your child some medication 
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to make him/her sleepy. This medication is called chloral hydrate and makes most chil-
dren sleepy enough for the testing to be done.  This is called sedation. Although chloral 
hydrate is used commonly to sedate children for various tests and procedures done in 
hospital there are risks to sedating a child. The most common side effects are: lack of 
sedation, nausea or prolonged sleepiness. At high doses there are risks of more severe 
side effects including slowing of breathing, deep sleepiness and an abnormal heart rate. 
For this reason we will not be using a high dose and we will not repeat the dose of seda-
tion. Sedating your child with chloral hydrate will mean they must wait at the clinic until 
they have woken up so that we can monitor their heart and breathing rate. This can take 
up to 2 to 4 hours. We will make sure there is a comfortable place to wait and that you 
have access to food and drinks should you have to wait. If you do not want your child 
to be sedated that is absolutely fine. We will attempt testing without sedation as with all 
children but without using sedation if they do not sleep. Your decision will not affect your 
involvement in the DCHLS and will not change your follow up or routine care in anyway.
What are the possible benefits to your child?
Although the infant lung function test will not be of any immediate benefit for your child 
it will record your babies’ lung growth and how well the lungs are working through the 
2 years of the study. This may be useful to your baby in the future if they should get a 
lung disease. The tests will also allow us to understand what is normal lung growth and 
function for babies in South Africa. This is important so we can better understand what 
causes damage to babies’ lungs in South Africa. In this way the study will help us to 
better understand the causes of illness in children, and identify the things that may harm 
their health. We hope that this will lead to improvements in child health.
What are the possible risks to your child?
 The lung function tests have no serious risk to your baby. The test is done with a mask 
over the babies’ nose and mouth while they are sleeping. They breathe air through the 
mask as they would normally. Sedation with chloral hydrate does have risks, the most 
serious being slowing of breathing or making the heart beat irregularly. This may happen 
if a very large dose or repeated doses are given. There is only a very small chance that 
this would happen with the standard dose used in this study. We will not repeat a dose 
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on any testing day. Your child will be monitored and a trained medical professional will 
always be present.
Who will do the testing on my infant?
There is a team of trained staff who will do the testing and help with all the study related 
questions and other tests on the day. For the lung function testing the team is: Dr Di-
ane Gray (child respiratory specialist), Ms Ane Alberts (respiratory technologist) and Sr 
Lauren Willemse (professional nurse and co-ordinator of this section of the study). They 
have all been trained in doing this testing.
Will I find out the results of the test?
Yes, within 2 weeks of testing a feedback letter should be sent to you. If your child is 
found to have an abnormal lung function test they will be referred by our team to the 
paediatric doctors at Paarl hospital for further assessment and any necessary treatment. 
Please check that the ILF study co-ordinator, Sr. Lauren Willemse has your correct ad-
dress when you come for the test. 
What do I do if I have any questions?
If you have any questions about this study, you can ask study staff or contact Lauren 
Willemse or Diane Gray at 021 860 2802.  For questions about your rights as a study 
participant call the Research Ethics Committee, University of Cape Town, telephone: 
021-4066492.
I______________________________________________________________ 
the parent of ___________________________________________________________
have read and understood this form. My questions have been answered.  I voluntarily 
consent to my child having an Infant lung function test. In addition I consent/do not con-
sent (delete where applicable) to sedation for the 1 and 2 year testing if it is necessary. 
Signature: ____________________________ Date: ________________
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Appendix B
Drakenstein Child Lung Health Study – Infant lung function testing
Parent information sheet
Thank you for agreeing to be part of this study. This information sheet aims to explain 
what the infant lung function is for and what it entails for you and your baby.
Why is infant lung function being measured?
South African children have a high rate of chest problems such as pneumonia, asthma 
and cough. We know from studies done in other countries that there are many things 
that can be a risk for chest problems in young children such as poor growth, exposure to 
cigarette smoke and other air pollutants and infections. At present we do not know what 
the most important risks are for South African children nor what is normal lung function 
for South African babies as it has not been measured before. By measuring a baby’s 
lung function over time we can find out how big their lungs are, how well the lungs work 
and if they grow normally over time. This study will allow us to find out what is normal 
lung function in South African babies and will provide important information about what 
causes chest disease in children and the effect these things have on lung growth and 
later chronic chest problems. This will help us to understand how best to prevent and 
treat lung disease in our children.
What does infant lung function measure?
The test measures your baby’s lung size and breathing pattern. There are 4 different 
tests, but some are done at the same time. 
Tidal breathing flow volume test 
The first test measures how fast (flow) your baby breaths and how much (volume) they 
breathe with each normal breath. By doing this the equipment can calculate information 
about the growth and working of your babies lungs. 
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Exhaled nitric oxide test 
At the same time the equipment can measure the amount of a gas called nitric oxide 
(NO) that is in your baby’s breath when they breathe out. NO is a gas that is important in 
the working of some of our bodies functions. We all have NO in the air we breathe out. 
High levels of NO in our breath can mean our airways or breathing tubes are inflamed. 
This has been shown to happen with diseases such as asthma or exposure to pollutants 
such as cigarette smoke. 
Sulphur hexafluoride (SF6) multiple breath washout test 
We can also measure the size of your baby’s lungs and the way the different parts of the 
lungs contribute to breathing. We do this by adding an inert gas (gas that does not get 
absorbed into the body) called SF6 to the air the baby breaths for a short period. This 
gas is not smelly or dangerous to your baby. 
Forced oscillation technique
This test uses sound waves to test how the baby’s lungs function and can pick up early 
problems with infants lung growth and function. 
How is the test done?
All the tests are done during quiet normal breathing (tidal breathing) when your baby is 
asleep. Your baby will need to be asleep and, while lying on his/her back, a face mask 
with air flowing through a flow meter will be placed over your baby’s nose and mouth. 
This can take all the measurements mentioned above. Often babies wriggle, sigh or 
wake and so sometimes we will need to repeat the test. We need to try and get 3 good 
tests. Depending on how deeply baby is sleeping it can take anywhere from 20 min to 1 
hour. 
As mentioned the test can be done during normal sleep for babies. However for the 
testing at 1 and 2 years of age, if your child is unable to stay asleep for the test we may 
need to give your baby some sedation or medicine that will make your baby sleepy. This 
medication is called chloral hydrate and is used commonly for this reason around the 
world. The benefit of this medication is that it can help your child sleep without signifi-
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cantly affecting his/her breathing pattern. If your child requires sedation he/she will need 
to wait for the sedation to wear off (1-2 hours) before you can go home. There will always 
be a nurse or doctor with your baby during testing (with or without sedation).
Who will do the testing on my infant?
There is a team of trained staff who will do the testing and help with all the study related 
questions and other tests on the day. For the lung function testing the team is: Dr Diane 
Gray (child respiratory specialist), Ms Ane Alberts (respiratory technologist) and Sr. Lau-
ren Macmillan (registered nurse and co-ordinator of this section of the study). You can 
contact them on: 021 860 2802 if you have any concerns or questions.
Will I find out the results of the test?
Yes, within 2 weeks of testing a feedback letter should be sent to you. Please check that 
the ILF study co-ordinator, Sr. Lauren Macmillan has your correct address when you 
come for the test.
What if I have questions about the infant lung function study?
If you have any questions about this study, you can ask the study staff or contact Lauren 
Willemse or Diane Gray of the infant lung function team at Paarl Hospital, telephone: 
021 860 2802.  For questions about your rights as a study participant call the Research 
Ethics Committee, University of Cape Town, telephone: 021-406 6492.
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UNIVERSI1Y OF CAPE TOWN 
' 
04 December 2012 
HREC REF: 423/2012 
Prof H Zar 
Paediatrics 
Red Cross War Memorial Children's Hospital 
Rondebosch 
Dear Prof Zar 
Faculty of Health Sciences 
Faculty of Health Sciences Human Research Ethics Committee 
Room E52-24 Groote Schuur Hospital Old Main Building 
Observatory 7925 
Telephone [021] 406 6338 • Facsimile (021] 406 6411 
e-mail: sumayah.ariefdien@uct.ac.za 
PROJECT TITLE: DRAKENSTEIN CHILD LUNG HEALTH STUDY - INFANT LUNG FUNCTION SUB- STUDY (LINKED TO 
HREC 401/2009} 
pf 
Thank you for addressing the issues raised by the Human Research Ethics Committee. 
It is a pleasure to inform you that the HREC has formally approved the above mentioned study. 
Approval is granted for one year till the 28 December 2013. 
Please submit a progress form, using the standardised Annual Report Form, if the study continues beyond the 
approval period. Please submit a Standard Closure form, if the study is completed within the approva l period. 
Please supply the SOP for Child sedation as per your response for the HREC's records. 
Please note that the ongoing ethical conduct of the study remains the responsibility of the principal investigator. 
Please quote the HREC. REF in all your correspondence. 
Yours sincerely 
PROFESSOR M BLOCKMAN 
CHAIRPERSON, HSF HUMAN ETHICS 
Federal Wide Assurance Number: FWA00001637. 
Institutional Review Board (IRB) number: IRB00001938 
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